var title_f24_2_24608="New World CL ulceration";
var content_f24_2_24608=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    New World cutaneous leishmaniasis ulcer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ulcer with sporotrichoid extension into local lymphatics.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention and Drs. Martins Castro and Lucille K Georg.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24608=[""].join("\n");
var outline_f24_2_24608=null;
var title_f24_2_24609="MRI ventriculomegaly atrophy versus NPH";
var content_f24_2_24609=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F76428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F76428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    MRI ventriculomegaly atrophy versus NPH",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Axial T2-weighted image at level of lateral ventricles in a patient with Alzheimer disease demonstrates increased size of the ventricular system in proportion to sulcal dilatation, consistent with brain parenchymal volume loss. B) Axial T2-weighted image at level of lateral ventricles in a patient with normal pressure hydrocephalus shows ventricular dilatation out of proportion to the sulci.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24609=[""].join("\n");
var outline_f24_2_24609=null;
var title_f24_2_24610="Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)";
var content_f24_2_24610=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15325\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/22/29024\">",
"         Upper digestive tract",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_table\" href=\"UTD.htm?30/7/30843\">",
"          Medicines used to treat acid reflux",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?42/0/43011\">",
"         Patient information: Cough in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?37/30/38373\">",
"         Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/50/32547\">",
"         Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/16/16643\">",
"         Patient information: Acid reflux (gastroesophageal reflux) in infants (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/39/2676\">",
"         Patient information: Barrett's esophagus (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/acid-reflux-gastroesophageal-reflux-disease-in-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H21944583\">",
"      <span class=\"h1\">",
"       What is acid reflux?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Acid reflux is when the acid that is normally in your stomach backs up into the tube that carries food from your mouth to your stomach (",
"      <a class=\"graphic graphic_figure graphicRef55616 \" href=\"UTD.htm?28/22/29024\">",
"       figure 1",
"      </a>",
"      ). This tube is called the esophagus. Another term for acid reflux is &ldquo;gastroesophageal reflux disease,&rdquo; or GERD.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21944590\">",
"      <span class=\"h1\">",
"       What are the symptoms of acid reflux?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Burning in the chest, known as heartburn",
"       </li>",
"       <li>",
"        Burning in the throat or an acid taste in the throat",
"       </li>",
"       <li>",
"        Stomach or chest pain",
"       </li>",
"       <li>",
"        Trouble swallowing",
"       </li>",
"       <li>",
"        Having a raspy voice or a sore throat",
"       </li>",
"       <li>",
"        Unexplained cough",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21944597\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to improve my symptoms?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You might feel better if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Lose weight (if you are overweight)",
"       </li>",
"       <li>",
"        Raise the head of your bed by 6 to 8 inches (for example, by putting blocks of wood under 2 legs of the bed or a Styrofoam wedge under the mattress)",
"       </li>",
"       <li>",
"        Avoid foods that make your symptoms worse (examples include coffee, chocolate, alcohol, peppermint, and fatty foods)",
"       </li>",
"       <li>",
"        Cut down on the amount of alcohol you drink",
"       </li>",
"       <li>",
"        Stop smoking, if you smoke",
"       </li>",
"       <li>",
"        Eat a bunch of small meals each day, rather than two or three big meals",
"       </li>",
"       <li>",
"        Avoid lying down for 3 hours after a meal",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21944604\">",
"      <span class=\"h1\">",
"       What treatments can help with my acid reflux?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are three main types of medicines that can help with the symptoms of acid reflux: antacids, histamine blockers, and proton pump inhibitors (",
"      <a class=\"graphic graphic_table graphicRef78918 \" href=\"UTD.htm?30/7/30843\">",
"       table 1",
"      </a>",
"      ). All of these medicines work by reducing or blocking stomach acid. But they each do that in a different way.",
"     </p>",
"     <p>",
"      You can buy antacids without a prescription. They can relieve mild symptoms, but they work only for a short time. You can also buy most histamine blockers without a prescription. They are stronger and last longer than antacids.",
"     </p>",
"     <p>",
"      Proton pump inhibitors are the most effective medicines in treating GERD. Two of these medicines are sold without a prescription. But there are other versions that your doctor or nurse can prescribe.",
"     </p>",
"     <p>",
"      Sometimes acid reflux medicines are less expensive if you get them with a prescription. Other times nonprescription medicines are less expensive. If cost is a concern for you, ask your pharmacist how you might reduce the cost of your medicines.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21944611\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse about my acid reflux?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people can manage their acid reflux on their own by changing their habits or taking nonprescription medicines. But you should see a doctor or nurse if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Your symptoms are severe or last a long time",
"       </li>",
"       <li>",
"        You cannot seem to control your symptoms",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You should also see a doctor or nurse",
"      <strong>",
"       right away",
"      </strong>",
"      if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have trouble swallowing, or feel as though food gets &ldquo;stuck&rdquo; on the way down",
"       </li>",
"       <li>",
"        Lose weight when you are not trying to",
"       </li>",
"       <li>",
"        Have chest pain",
"       </li>",
"       <li>",
"        Choke when you eat",
"       </li>",
"       <li>",
"        Vomit blood or have bowel movements that are black or look like tar",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21944618\">",
"      <span class=\"h1\">",
"       What if my child or teenager has acid reflux?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your child or teenager has acid reflux, take him or her to see a doctor or nurse. Do not give your child medicines to treat acid reflux without talking to a doctor or nurse.",
"     </p>",
"     <p>",
"      In children, acid reflux can be caused by a number of problems. It's important to have a doctor or nurse check for these problems before trying any treatments.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21944625\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/0/43011?source=see_link\">",
"       Patient information: Cough in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/39/2676?source=see_link\">",
"       Patient information: Barrett's esophagus (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/30/38373?source=see_link\">",
"       Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/50/32547?source=see_link\">",
"       Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?16/16/16643?source=see_link\">",
"       Patient information: Acid reflux (gastroesophageal reflux) in infants (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/2/24610?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15325 Version 5.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-27EA24A548-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24610=[""].join("\n");
var outline_f24_2_24610=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21944583\">",
"      What is acid reflux?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21944590\">",
"      What are the symptoms of acid reflux?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21944597\">",
"      Is there anything I can do on my own to improve my symptoms?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21944604\">",
"      What treatments can help with my acid reflux?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21944611\">",
"      Should I see a doctor or nurse about my acid reflux?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21944618\">",
"      What if my child or teenager has acid reflux?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21944625\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15325\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/22/29024\">",
"      Upper digestive tract",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_table\" href=\"UTD.htm?30/7/30843\">",
"       Medicines used to treat acid reflux",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/30/38373?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/50/32547?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/16/16643?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux) in infants (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/39/2676?source=related_link\">",
"      Patient information: Barrett's esophagus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/0/43011?source=related_link\">",
"      Patient information: Cough in adults (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_2_24611="Tirofiban: Patient drug information";
var content_f24_2_24611=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tirofiban: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/2/13351?source=see_link\">",
"     see \"Tirofiban: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F228333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aggrastat&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F228334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aggrastat&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used during a heart treatment to protect the arteries.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691335",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower the number of heart attacks in patients who have unstable angina or mild heart attacks.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tirofiban or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703239",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Aneurysm, arteriovenous malformations, bleeding problems, brain tumor, low platelet count, recent surgery or injury, stroke, or very high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fall or crash when you hit your head. Talk with your doctor even if you feel fine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012472\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12011 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-92133E1D40-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24611=[""].join("\n");
var outline_f24_2_24611=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228333\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228334\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012463\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012462\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012467\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012468\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012470\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012465\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012472\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/2/13351?source=related_link\">",
"      Tirofiban: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_2_24612="Aluminum hydroxide and magnesium hydroxide: Patient drug information";
var content_f24_2_24612=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aluminum hydroxide and magnesium hydroxide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1895?source=see_link\">",
"     see \"Aluminum hydroxide and magnesium hydroxide: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/3/19511?source=see_link\">",
"     see \"Aluminum hydroxide and magnesium hydroxide: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F132519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alamag [OTC];",
"     </li>",
"     <li>",
"      Mag-Al Ultimate [OTC];",
"     </li>",
"     <li>",
"      Mag-Al [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F132520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Diovol&reg;;",
"     </li>",
"     <li>",
"      Diovol&reg; Ex;",
"     </li>",
"     <li>",
"      Gelusil&reg; Extra Strength;",
"     </li>",
"     <li>",
"      Mylanta&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10013938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691873",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat heartburn and upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701479",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aluminum, magnesium, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have PKU, talk with your doctor. Some products have phenylalanine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take other drugs within 1 hour of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 1 to 3 hours after meals as an antacid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694590",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chew or crush tablet well. Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10013943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10013948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11444 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-73A94EB3C9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24612=[""].join("\n");
var outline_f24_2_24612=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132519\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132520\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013938\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013940\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013939\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013944\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013945\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013947\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013942\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013943\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013948\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013949\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1895?source=related_link\">",
"      Aluminum hydroxide and magnesium hydroxide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/3/19511?source=related_link\">",
"      Aluminum hydroxide and magnesium hydroxide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_2_24613="Breast MRI of invasive ductal cancer kinetic color map";
var content_f24_2_24613=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F74017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F74017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Breast MRI of invasive ductal cancer kinetic color map",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 544px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The figure shows a breast MRI of a patient with biopsy proven invasive ductal cancer in the left breast.",
"    <br>",
"     (A) The T1-weighted fat-suppressed contrast-enhanced axial image shows an irregular lobulated enhancing mass with central signal void corresponding to the percutaneous clip that was placed at time of core biopsy.",
"     <br>",
"      (B) The corresponding kinetic color map demonstrates predominantly washout kinetics highly suspicious for malignancy.",
"      <br>",
"       (C) Enhancement curves show mixed plateau and washout kinetics indicative of malignancy.",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24613=[""].join("\n");
var outline_f24_2_24613=null;
var title_f24_2_24614="Laboratory evaluation of neutropenia and neutrophil dysfunction";
var content_f24_2_24614=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Laboratory evaluation of neutropenia and neutrophil dysfunction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24614/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24614/contributors\">",
"     Thomas D Coates, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24614/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24614/contributors\">",
"     Laurence A Boxer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24614/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24614/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/2/24614/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The polymorphonuclear neutrophil (PMN) is the primary defense against bacterial and fungal invasion. Although there are some subtle findings that may lead one to suspect either neutropenia or neutrophil dysfunction as a cause of recurrent infection, there is a great deal of overlap in the clinical presentations with those of other immune deficiency states.",
"   </p>",
"   <p>",
"    The recognition of neutropenia is straightforward (ie, an absolute neutrophil count",
"    <span class=\"nowrap\">",
"     &lt;1500/microL),",
"    </span>",
"    while the recognition of neutrophil functional deficiency is more complex. Unless there is strong historical evidence to suggest a primary neutrophil dysfunction syndrome, the humoral and T cell systems should be thoroughly investigated before extensive evaluation of neutrophil function is initiated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although a large number of neutrophil function assays have been described, the low frequency of requests makes them inappropriate for most routine clinical laboratories, and many are used mostly for research purposes. Only the general aspects of each test will be described here. Information concerning specimen requirements, reagents, and the specific procedures to be followed are available elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/1\">",
"     1",
"    </a>",
"    ]. Clinical approaches to the patient with neutropenia or neutrophil dysfunction are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"     \"Overview of neutropenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link\">",
"     \"Primary disorders of phagocytic function: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LABORATORY APPROACH TO THE NEUTROPENIC PATIENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutropenia is defined as an absolute neutrophilic granulocyte count (ANC) of less than",
"    <span class=\"nowrap\">",
"     1500/microL,",
"    </span>",
"    although there are age and racial differences. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"     \"Overview of neutropenia\"",
"    </a>",
"    .) For example, newborn infants have elevated granulocyte counts in the first days of life, and certain populations of blacks and Yemenite Jews normally have lower granulocyte counts.",
"   </p>",
"   <p>",
"    The ANC is equal to the product of the white blood cell count (WBC) and the fraction of polymorphonuclear cells (PMNs) and band forms noted on the differential analysis; neutrophilic metamyelocytes and younger forms are not included in this calculation:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;ANC &nbsp;= &nbsp;WBC",
"    <span class=\"nowrap\">",
"     (cells/microL)",
"    </span>",
"    &nbsp;x &nbsp;percent (PMNs &nbsp;+ &nbsp;bands) &nbsp;&divide; &nbsp;100",
"   </p>",
"   <p>",
"    Propensity to infection and the attendant need for hospitalization for infection in neutropenic patients are both related to the ANC. This relationship holds particularly well in situations in which there is a relatively recent decrease in neutrophil production. Thus, patients with neutropenia secondary to chemotherapy, marrow failure, or marrow exhaustion are at great risk for overwhelming bacterial infection, whereas children with chronic benign neutropenia of infancy may have neutrophil counts less than",
"    <span class=\"nowrap\">",
"     200/microL",
"    </span>",
"    for months or years and have no serious infectious problems.",
"   </p>",
"   <p>",
"    Older patients with immune neutropenia may have severe depression of their neutrophil counts and yet suffer no serious episodes of infection. However, some antibodies associated with neutropenia have been shown to impair neutrophil function, which may explain why certain patients with immune neutropenia have more serious problems with infection than others. In immune neutropenia, the bone marrow is cellular, with a normal differential count. A maturation arrest within the granulocyte series may be seen if the antibody is directed against a specific stage of PMN development.",
"   </p>",
"   <p>",
"    Neutropenia can be due to decreased production of granulocytes, shift of granulocytes from the circulating pool to marginated or tissue pools, peripheral destruction, or a combination of these causes. Since the laboratory characteristics of many of the neutropenias overlap, the differential diagnosis can be very difficult and depends, at least in part, on the clinical history. The cellularity of the bone marrow, presence of malignant cells, chromosomal abnormalities suggesting malignant clones, and myeloid nuclear abnormalities can be determined by marrow examination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13689?source=see_link\">",
"     \"Evaluation of bone marrow aspirate smears\"",
"    </a>",
"    .) Associated alterations in gamma globulin production, natural killer cell activity, or T cell activity can be determined by methods outlined elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several of the acquired neutropenias are associated with the presence of antineutrophil antibodies, and detection of these antibodies may be helpful. We take a very practical approach to the use of antineutrophil antibody assays in clinical medicine. Many assays designed to study these interesting disorders are available. Each has problems with false-negative and false-positive results. The results must be used in conjunction with other clinical information in making a decision regarding management of the patient. Thus, ease of performance, cost, and reliability of interpretation, rather than ability to precisely characterize the antibody, have driven the selection of assays presented in this review (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Tests for the presence of neutrophil antibodies'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TESTS FOR THE PRESENCE OF NEUTROPHIL ANTIBODIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two main techniques used to detect the presence of antibodies directed against neutrophils: immunofluorescence and agglutination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Immunofluorescence assay",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibodies directed against neutrophils may be responsible for otherwise unexplained cases of neutropenia. The assay we employ detects IgG and IgM antibodies present in serum that are capable of binding to normal neutrophils.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     General test principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sera from patients are incubated with neutrophils from three normal donors. Pooled serum obtained from several normal controls is kept frozen and is run against the normal donor neutrophils as a negative control. The antibody bound to test neutrophils is then labeled with fluorescent goat anti-human antibody (anti-IgG and anti-IgM). The amount of fluorescent labeled antibody bound to the neutrophil is detected with a flow cytometer.",
"   </p>",
"   <p>",
"    Results obtained from patient sera are compared with those of the standardized pool run the same day. Only a distinct shift in the primary fluorescence peak is considered positive. Weak as well as strong positive reactions should be noted. While calculation of mean or median fluorescence channel numbers has been used for comparison with the control, we find that inspection of the histograms is also helpful. A subpopulation of positive cells, which may be missed if only the mean or median channel numbers are compared, may be seen when the original histogram is examined. We consider evidence of increased binding of antibody to neutrophils from any of the control donors to be abnormal. The report is descriptive (eg, \"the patient's serum contained IgG antibody which bound to PMN from one of three normal donors\") [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of frozen-stored granulocytes for this assay has been suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/5\">",
"     5",
"    </a>",
"    ]. This method allows representative panel granulocytes to be stored long-term in aliquots, resulting in more uniform testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antineutrophil antibodies have been detected in 96 percent of children with idiopathic benign neutropenia of infancy when both immunofluorescence and agglutination assays are used; agglutinins are present in 78 percent, and the immunofluorescence assay is positive in 88 percent.",
"   </p>",
"   <p>",
"    A positive immunofluorescence test suggests that an immunologic mechanism is involved, but does not preclude the possibility that the antibody is bound to PMN but is not responsible for the neutropenia. Similarly, a negative result does not exclude the possibility that an antibody-mediated mechanism is involved. As an example, antibodies against neutrophil progenitors have been detected in sera from patients with idiopathic neutropenia in whom no antibody to mature neutrophils could be found.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     EVALUATION FOR NEUTROPHIL DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with neutrophil dysfunction present with chronic recurrent bacterial infections. Severe chemotactic defects in particular have been associated with chronic skin and mucosal infections. These skin infections tend to be severe enough to lead to permanent scarring or cause skin lesions requiring incision and drainage. Primary neutrophil dysfunction significant enough to cause clinical disease accounts for less than 6 percent of all primary immune deficiency states. Thus, unless there is a family history suggestive of a neutrophil dysfunction syndrome, disorders of immunoglobulins, complement, or T cells should be ruled out before a primary neutrophil dysfunction syndrome is considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .) One possible exception to this rule, because of ease of performing the screening test, is chronic granulomatous disease (CGD). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link&amp;anchor=H4#H4\">",
"     \"Primary disorders of phagocytic function: An overview\", section on 'Chronic granulomatous disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The normal human PMN becomes activated when it senses the presence of serum factors, such as C5A, kallikrein, or bacterial peptides. The circulating neutrophil attaches to the endothelium of the blood vessel, moves along the gradient of a chemoattractant until it comes in contact with the organism, adheres to the organism, and ingests and kills it. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/41/17048?source=see_link\">",
"     \"Determinants of neutrophil movement\"",
"    </a>",
"    .) There are abnormalities intrinsic to the PMN that can occur at each of these stages, either secondary to drugs or toxins or due to primary defects in the neutrophil. While it may be possible to detect differences at each of these stages of function, it is usually difficult to ascertain whether these differences are actually the cause of the disease process unless the abnormalities are profound.",
"   </p>",
"   <p>",
"    A few neutrophil dysfunction syndromes can be diagnosed or at least suspected on morphologic grounds alone. In the case of Chediak-Higashi syndrome, the morphologic features, giant granules in the cytoplasm of PMNs and lymphocytes, are pathognomonic.",
"   </p>",
"   <p>",
"    There are numerous clinical situations that lead to secondary neutrophil dysfunction. In addition, certain neutrophil assays are more sensitive to secondary dysfunction than others. These are noted in the interpretation sections associated with the specific assays. In general, one should not hesitate to screen for neutrophil dysfunction even though the patient is currently sick. If the test is abnormal, however, interpretation of the results as indicative of a primary neutrophil dysfunction syndrome must be viewed with some caution. Usually, the magnitude of the deficiency seen with the listed primary neutrophil dysfunction syndromes is much greater than that seen in any secondary dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Bactericidal killing assay",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bactericidal killing assay measures several aspects of neutrophil function. In conditions such as chronic granulomatous disease (CGD) or severe deficiency of glucose-6-phosphate dehydrogenase, PMN lack the respiratory burst, leading to poor generation of bactericidal reduced oxygen metabolites and a very abnormal bacterial killing assay. Other conditions, such as leukocyte adhesion deficiency, actin dysfunction, or Chediak-Higashi syndrome, which have defects in chemotaxis and phagocytosis, also produce intermediate abnormalities in bactericidal killing. Overall, the most common cause of a severe abnormality in bactericidal killing is chronic granulomatous disease (CGD).",
"   </p>",
"   <p>",
"    One advantage of this assay for a clinical laboratory is that it requires only an ability to culture Staph aureus. The methods we employ are modifications of an assay originally described elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. If the bactericidal killing assay is abnormal and the NBT test is normal (see below), one can infer a defect in phagocytosis. The killing assay is also useful for assessing the patient's serum opsonizing capabilities by substituting patient serum for control serum in the assay system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracellular killing of S. aureus usually occurs rapidly, and in normal granulocytes more than 90 percent of bacteria are killed within 30 minutes. Since the number of viable bacteria is recorded as colony forming units, clumping of bacteria before incubation will give falsely low colony counts. The percent killing is calculated by comparing colony counts in phagocytic mixtures with and without phagocytic cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Chemiluminescence assay",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human phagocytic cells respond to stimulation with an oxidative burst, with energy released as light (ie, chemiluminescence). Assays of chemiluminescence therefore measure the endpoint of the oxidative response of granulocytes and other phagocytic cells to a variety of stimuli. Beta counters (liquid scintillation counters) or specialized chemiluminometers are used for quantitation of the response. Counters must have only one photomultiplier tube, since coincidence counting cannot be used in this method. The sensitivity of the assay is enhanced by using luminol or lucigenin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic granulomatous disease lack a chemiluminescence response. Mothers and other female relatives of patients with X-linked chronic granulomatous disease have intermediate values. Patients with",
"    <span class=\"nowrap\">",
"     CD11/CD18",
"    </span>",
"    surface glycoprotein deficiency may have normal chemiluminescence after stimulation with soluble stimulators, such as phorbol myristate acetate (PMA), but delayed and diminished chemiluminescence after stimulation with opsonized particles.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     NBT slide test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The NBT test is a measure of the respiratory burst in neutrophils and is used to screen for CGD. The respiratory burst of the neutrophil is fairly resistant to the vagaries of the method of handling and usually will remain intact for at least 24 hours. Thus, this assay can be performed on mailed or delayed specimens if necessary.",
"   </p>",
"   <p>",
"    Neutrophils will reduce the dye NBT, a clear yellow water-soluble compound, to formazan upon stimulation of the respiratory burst. Formazan thus formed precipitates as a dark blue granular substance, which remains trapped in the cytoplasm. Patients with CGD lack a component of the oxidase system, which produces superoxide anion and thus cannot reduce NBT to formazan.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Results are interpreted as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Normal (positive test) &mdash; large cells with an orange-red nucleus and blue cytoplasm",
"     </li>",
"     <li>",
"      Abnormal (negative test) &mdash; small cells with an orange-red nucleus and colorless cytoplasm",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A patient with CGD usually has no positive cells. Carriers of the autosomal recessive form of CGD usually have normal NBT results. Maternal carriers of the X-linked recessive form of CGD most commonly have 20 to 70 percent positive cells. In classic X-linked CGD, none of the patient neutrophils reduces NBT. Thus, there will be no blue staining of the cytoplasm. In the X-linked carrier state, usually between 30 and 80 percent of the cells will be NBT negative and the remainder are clearly NBT positive (blue). There is, however, some variability in carrier state detection, and one may see percentages ranging from 10 to 90 percent negative cells in the X-linked carrier state.",
"   </p>",
"   <p>",
"    There are numerous recognized variants of CGD. Some well-documented X-linked CGD patients have had a number of NBT positive or midrange NBT-positive results, others have had high percentages of NBT-positive cells, although usually the staining is less intense. These rare presentations of this very rare disease are difficult to interpret unless the pathologist or laboratory technician has extensive experience. Thus, we attach the caveat to all \"normal\" NBT reports stating that a more specific assay of neutrophil oxidative metabolism should be performed if the clinical index of suspicion is high. Nevertheless, the results of the NBT test will be clear-cut in over 90 percent of the cases.",
"   </p>",
"   <p>",
"    Other confirmatory tests for CGD include the superoxide assay and the chemiluminescence assay, both of which are well standardized. Both the NBT and chemiluminescence tests have been performed on fetal neutrophils for prenatal diagnosis. Although the genes for several components of the oxidase have been cloned, no reliable prenatal diagnosis techniques using DNA technology are yet available. Patients with CGD should be referred to a specialized laboratory for complete biochemical characterization of their defects [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/6,7,9,10\">",
"     6,7,9,10",
"    </a>",
"    ]. CGD is recessively inherited, and some decreased expression may be seen in carriers. There are also patients with low expression who have clinically less severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/6,10,11\">",
"     6,10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link&amp;anchor=H4#H4\">",
"     \"Primary disorders of phagocytic function: An overview\", section on 'Chronic granulomatous disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10826?source=see_link\">",
"     \"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Sources of error",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 95 percent of normal neutrophils should reduce NBT upon stimulation. It is important to include the unstimulated control slide for this assay; unstimulated NBT slides may score higher with heparinized blood than with other anticoagulants because",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    can form a precipitate with NBT. The unstimulated control slide will also serve as an indicator of whether the NBT reagent needs to be refiltered or replaced. If the test background is unacceptably high in unstimulated cells, the assay should be repeated, decreasing the 15-minute incubation time to seven minutes.",
"   </p>",
"   <p>",
"    In general, there are not many secondary causes of abnormalities in the NBT test. The drug D-penicillamine can give a completely abnormal NBT test mimicking results for CGD. Most infectious and inflammatory disorders result in enhanced NBT reduction. A few specific infections, such as influenza virus, certain strains of streptococcus, and Candida albicans, can suppress the neutrophil respiratory burst.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Neutrophil chemotaxis testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two standardized methods for assessment of chemotaxis: chemotaxis under agarose and chemotaxis through Millipore filters in a Boyden chamber and a multiwell Millipore filter assay block.",
"   </p>",
"   <p>",
"    The under-agarose assay system is one of the easiest systems to use and requires a minimum of special equipment; it does not require radioactivity or laborious cell counting. Since the assay is interpreted visually, its success is easy to determine. It is particularly important that this assay be regularly performed. Normal control values with means and standard deviations should be established for each laboratory, since there is considerable population variability among normal controls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutrophils placed in the middle well of an agarose plate will migrate under the agarose in response to a chemotactic gradient generated by FMLP in an adjacent well. Comparison is made with a normal control run concurrently. The results should fall within two standard deviations (SD) of the laboratory mean. Normal ranges in our laboratory (data from computerized analysis) are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Leading front (LF): range 1.15 to 1.75 mm (mean &plusmn; 2 SD)",
"     </li>",
"     <li>",
"      Random migration (RM): range 0.15 to 0.77 mm (mean &plusmn; 2 SD)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Chemotaxis results must be interpreted with respect to the patient's age as well as population standards. A normal control donor should be assayed on each day to determine whether some vagary of cell preparation has caused problems with the assay. Usually, normal newborn infant chemotaxis is 40 to 60 percent that of an adult control. Infant chemotaxis gradually increases over the first six months of life and approaches normal adult ranges by one year of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Sources of error",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutrophil chemotaxis testing is sensitive to secondary influences and is very sensitive to methods of cell preparation. Neutrophil chemotaxis should not be performed on blood samples that have been mailed overnight or on blood that is more than a few hours old. Chemotaxis can be affected by drugs such as corticosteroids, anti-inflammatory agents, and chemotherapeutic agents. Substances secreted by monocytes in response to organisms such as S. aureus can inhibit chemotaxis. Chemotactic defects have also been described in patients with certain oral infections (eg, capnocytophaga). Patients with chronic inflammatory disease may express increased chemotaxis. In primary chemotactic deficiency states, there is usually a profound defect, with patients exhibiting almost no cell movement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24614/abstract/6,7,12,13\">",
"     6,7,12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641292\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recognition of neutropenia is straightforward (ie, an absolute neutrophil count [ANC]",
"    <span class=\"nowrap\">",
"     &lt;1500/microL),",
"    </span>",
"    while the recognition of neutrophil functional deficiency is more complex. Unless there is strong historical evidence to suggest a primary neutrophil dysfunction syndrome, the humoral and T cell systems should be thoroughly investigated before extensive evaluation of neutrophil function is initiated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641581\">",
"    <span class=\"h2\">",
"     Evaluation of neutropenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Propensity to infection and the need for hospitalization for infection in neutropenic patients are both related to the ANC. The evaluation and testing for neutropenia is covered elsewhere in UpToDate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"     \"Overview of neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641639\">",
"    <span class=\"h2\">",
"     Evaluation for neutrophil dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with neutrophil dysfunction present with chronic recurrent bacterial infections. Severe chemotactic defects in particular have been associated with chronic skin and mucosal infections. With the exception of testing for chronic granulomatous disease (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10826?source=see_link\">",
"     \"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis\"",
"    </a>",
"    ) and leukocyte adhesion deficiency (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22953?source=see_link\">",
"     \"Leukocyte adhesion deficiency\"",
"    </a>",
"    ), testing of neutrophil function should only be done in qualified research laboratories with significant experience and expertise. Even in the case of CGD and LAD, there are significant issues with results from some commercial laboratories, and clinicians who specialize in these disorders should interpret the results.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Coates TD, Beyer LL, Baehner RL. Laboratory evaluation of neutropenia and neutrophil dysfunction. In: Manual of Clinical Laboratory Immunology, 4th ed, Rose NR, de Macario EC, Fahey JL, et al (Eds), American Society for Microbiology, Washington, DC 1992.",
"    </li>",
"    <li>",
"     Coates TD, Baehner RL. Leukocytosis and leukopenia. In: : Basic Principles and Practice, Hoffman R , Benz EJ Jr, Shattil SJ, et al (Eds), Churchill Livingstone, New York 1991. p.552.",
"    </li>",
"    <li>",
"     Lalezari P, Pryce SC. Detection of neutrophil and platelet antibodies in immunologically induced neutropenia and thrombocytopenia. In: Manual of Clinical Immunology, 2nd ed, Rose NR, Friedman H (Eds), American Society for Microbiology, Washington, DC 1980. p.744.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24614/abstract/4\">",
"      Patrick CW, Milson TJ, McFadden PW, et al. Flow cytometry and cell sorting. Lab Med 1984; 15:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24614/abstract/5\">",
"      Nishimura M, Mitsunaga S, Juji T. Frozen-stored granulocytes can be used for an immunofluorescence test to detect granulocyte antibodies. Transfusion 2001; 41:1268.",
"     </a>",
"    </li>",
"    <li>",
"     Curnutte JT. Disorders of phagocyte function. In: Hematology: Basic Principles and Practice, Hoffman R , Benz EJ Jr, Shattil SJ, et al (Eds), Churchill Livingstone, New York 1991. p.571.",
"    </li>",
"    <li>",
"     Metcalf JA, Gallin JL, Nauseef WM, et al. Laboratory Manual of Neutrophil Function, Raven Press, New York 1986.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24614/abstract/8\">",
"      Quie PG, White JG, Holmes B, Good RA. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1967; 46:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24614/abstract/9\">",
"      Baehner RL, Nathan DG. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 1968; 278:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24614/abstract/10\">",
"      Curnutte JT, Babior BM. Chronic granulomatous disease. Adv Hum Genet 1987; 16:229.",
"     </a>",
"    </li>",
"    <li>",
"     Stites DP, Stobo JD, Wells JV. Basic and Clinical Immunology, Lange Medical Publications, Appleton &amp; Lange, Norwalk 1987. p.268.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24614/abstract/12\">",
"      Coates TD, Harman JT, McGuire WA. A microcomputer-based program for video analysis of chemotaxis under agarose. Comput Methods Programs Biomed 1985; 21:195.",
"     </a>",
"    </li>",
"    <li>",
"     Territo MC. Chemotaxis. In: Leukocyte function, Cline MJ (Ed), Churchill Livingstone, New York 1981. p.46.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8388 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-B09A38F648-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24614=[""].join("\n");
var outline_f24_2_24614=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H641292\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LABORATORY APPROACH TO THE NEUTROPENIC PATIENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TESTS FOR THE PRESENCE OF NEUTROPHIL ANTIBODIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Immunofluorescence assay",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - General test principles",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Interpretation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EVALUATION FOR NEUTROPHIL DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Bactericidal killing assay",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Chemiluminescence assay",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      NBT slide test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Interpretation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Sources of error",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Neutrophil chemotaxis testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Interpretation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Sources of error",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H641292\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H641581\">",
"      Evaluation of neutropenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H641639\">",
"      Evaluation for neutrophil dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10826?source=related_link\">",
"      Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/41/17048?source=related_link\">",
"      Determinants of neutrophil movement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13689?source=related_link\">",
"      Evaluation of bone marrow aspirate smears",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22953?source=related_link\">",
"      Leukocyte adhesion deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=related_link\">",
"      Overview of neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=related_link\">",
"      Primary disorders of phagocytic function: An overview",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_2_24615="Chronic ACD";
var content_f24_2_24615=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Allergic contact dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well demarcated patch of chronic allergic contact dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24615=[""].join("\n");
var outline_f24_2_24615=null;
var title_f24_2_24616="Angiographic control of nonvariceal gastrointestinal bleeding in adults";
var content_f24_2_24616=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Angiographic control of nonvariceal gastrointestinal bleeding in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24616/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24616/contributors\">",
"     Jonathan B Kruskal, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24616/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24616/contributors\">",
"     Lawrence S Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24616/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24616/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/2/24616/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the overwhelming majority of patients with upper or lower gastrointestinal (GI) bleeding, the bleeding either resolves spontaneously or can be controlled endoscopically. However, some patients have persistent or recurrent bleeding. Persistent or recurrent bleeding occurs in 7 to 16 percent of patients with upper GI bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/1\">",
"     1",
"    </a>",
"    ] and in up to 25 percent of patients with lower GI bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Such patients may require angiographic intervention to locate",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to treat the source of bleeding. Arterial GI bleeding can be controlled by the selective arterial infusion of vasoconstrictive drugs, by embolization of particulate matter into the bleeding artery, or by a combination of these techniques.",
"   </p>",
"   <p>",
"    This topic will review the angiographic methods available to control upper and lower GI bleeding. The diagnosis of upper and lower GI bleeding, as well as the endoscopic and surgical methods used to control GI bleeding are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28538?source=see_link\">",
"     \"Approach to acute upper gastrointestinal bleeding in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/7/30841?source=see_link\">",
"     \"Approach to resuscitation and diagnosis of acute lower gastrointestinal bleeding in the adult patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24826?source=see_link\">",
"     \"Overview of the treatment of bleeding peptic ulcers\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38679?source=see_link\">",
"     \"Colonic diverticular bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8410?source=see_link\">",
"     \"Angiodysplasia of the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiographic control of gastrointestinal (GI) bleeding is indicated for patients with upper or lower GI bleeding who fail to respond to medical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    endoscopic therapy. In patients with upper GI bleeding, angiographic control of bleeding is generally considered if endoscopic attempts at therapy have failed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/4\">",
"     4",
"    </a>",
"    ]. In patients with lower GI bleeding, angiographic control of bleeding is used as an alternative to surgery in hemodynamically unstable patients with severe bleeding or for patients with ongoing or recurrent bleeding following attempts to control the bleeding endoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24826?source=see_link&amp;anchor=H97407746#H97407746\">",
"     \"Overview of the treatment of bleeding peptic ulcers\", section on 'Interventional angiography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38679?source=see_link&amp;anchor=H9#H9\">",
"     \"Colonic diverticular bleeding\", section on 'Angiography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H331530\">",
"    <span class=\"h1\">",
"     LESION LOCALIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, angiographic control of gastrointestinal (GI) bleeding requires that the site of bleeding first be identified. This can be done with endoscopy, nuclear scintigraphy (tagged red blood cell scan), computed tomographic angiography, or standard angiography. These diagnostic tests are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/7/30841?source=see_link&amp;anchor=H4#H4\">",
"     \"Approach to resuscitation and diagnosis of acute lower gastrointestinal bleeding in the adult patient\", section on 'Diagnostic evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28538?source=see_link&amp;anchor=H9942984#H9942984\">",
"     \"Approach to acute upper gastrointestinal bleeding in adults\", section on 'Upper endoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to attempting angiographic bleeding control, the bleeding vessel(s) are identified angiographically. Optimally, prior to undergoing angiography, patients should have a serum creatinine less than 1.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    with an estimated glomerular filtration rate greater than 60",
"    <span class=\"nowrap\">",
"     mL/min/1.73",
"    </span>",
"    m",
"    <sup>",
"     2",
"    </sup>",
"    , an international normalized ratio (INR) less than 1.5, and a platelet count greater than",
"    <span class=\"nowrap\">",
"     50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/6\">",
"     6",
"    </a>",
"    ]. If needed, fresh frozen plasma or platelets should be transfused prior to or during the procedure.",
"   </p>",
"   <p>",
"    For lower GI bleeding, the evaluation typically begins with the superior mesenteric artery or the inferior mesenteric artery, based upon the suspected location of the bleeding source, whereas for upper GI bleeding it begins with the celiac artery or the superior mesenteric artery. Contrast extravasation into the bowel lumen is considered definitive evidence of a bleeding site. Indirect evidence includes visualization of an aneurysm or pseudoaneurysm, filling of spaces outside the bowel lumen (diverticula), early draining vessels (angiodysplasia), neovascularity (tumors), arteriovenous fistulas, and hyperemia (colitis).",
"   </p>",
"   <p>",
"    Once the site of bleeding is identified, angiographic therapy can be delivered. In addition, in patients with upper GI bleeding, treatment with empiric embolization (ie, embolization of a vessel thought to be supplying the bleeding source without bleeding having been demonstrated on angiography) can be performed provided the bleeding site was identified endoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/7\">",
"     7",
"    </a>",
"    ]. This can be aided by placement of clips at the bleeding site during endoscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H331951\">",
"    <span class=\"h1\">",
"     ANGIOGRAPHIC THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiographic therapies include the infusion of vasoconstricting medications or the delivery of agents to mechanically occlude the vascular supply of the bleeding lesion (embolization).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Intra-arterial vasopressin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     Vasopressin",
"    </a>",
"    causes generalized vasoconstriction via a direct action upon vessel walls, especially the arterioles, capillaries, and venules. Infusion of vasopressin produces a rapid reduction in local blood flow that gradually returns to normal several hours after the infusion has been terminated. The goal is for the decrease in perfusion pressure to permit stable clot formation at the bleeding site. However, rebleeding once the vasopressin has been stopped is common, and its use can be associated with significant ischemic events. As a result, many patients are instead treated with angiographic embolization [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H332355\">",
"     'Efficacy of intra-arterial vasopressin'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H4\">",
"     'Embolization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     Vasopressin",
"    </a>",
"    may be particularly helpful in patients with:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopically documented hemorrhagic gastropathy",
"     </li>",
"     <li>",
"      Poor collateral blood supply to the bowel (a contraindication to embolization), such as following bowel surgery",
"     </li>",
"     <li>",
"      Bleeding from anastomotic ulcers or endoscopic biopsy sites",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72428466\">",
"    <span class=\"h3\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients will respond to a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    infusion of 0.2 pressor",
"    <span class=\"nowrap\">",
"     units/minute.",
"    </span>",
"    Repeat angiography is performed 30 minutes later and the rate is increased to 0.3 to 0.4",
"    <span class=\"nowrap\">",
"     units/minute",
"    </span>",
"    if the bleeding persists. If bleeding is controlled, the infusion is continued in an intensive care setting for 12 to 48 hours, and then tapered over 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/6,10\">",
"     6,10",
"    </a>",
"    ]. Patients not responding to an infusion rate of 0.4",
"    <span class=\"nowrap\">",
"     units/minute",
"    </span>",
"    are unlikely to respond to higher doses and require alternative therapies, such as embolization or surgery.",
"   </p>",
"   <p>",
"    Most authors believe that intra-arterial",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    is more effective than an intravenous infusion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. While intravenous infusion can control upper GI and left sided colonic bleeding in some cases, it is seldom used clinically [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72428395\">",
"    <span class=\"h3\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     Vasopressin",
"    </a>",
"    causes peripheral vasoconstriction that can result in ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. As a result, it should be used with caution in patients with coronary artery disease, congestive cardiomyopathy, severe hypertension, or severe peripheral vascular disease. It can also cause arrhythmias, especially bradycardia, and water retention leading to hyponatremia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Embolization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Embolization works by mechanically occluding the arterial blood supply to the bleeding site. Embolization should only be performed by interventional radiologists experienced with the technique because of the risk of causing bowel wall ischemia and infarction. In addition, the vessel must be accessible for selective catheterization of the bleeding site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for embolization include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Failed",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      infusion (or contraindication to the use of vasopressin)",
"     </li>",
"     <li>",
"      Active bleeding occurring at a rate greater than 0.5",
"      <span class=\"nowrap\">",
"       mL/minute",
"      </span>",
"      that is visible angiographically and amenable to percutaneous access",
"     </li>",
"     <li>",
"      Pyloroduodenal bleeding",
"     </li>",
"     <li>",
"      Hemobilia",
"     </li>",
"     <li>",
"      Bleeding into pancreatic pseudocysts or from visceral artery aneurysms",
"     </li>",
"     <li>",
"      Underlying coagulopathy",
"     </li>",
"     <li>",
"      Bleeding from attempted endoscopic coagulation of gastric ulcers",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Materials used for embolization are either temporary or permanent. An autologous blood clot was initially used as a short-acting material, but it lysed too rapidly to be clinically useful [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/17\">",
"     17",
"    </a>",
"    ]. Mixing the clot with epsilon",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/38/30311?source=see_link\">",
"     aminocaproic acid",
"    </a>",
"    stabilized the clot, preventing immediate lysis, but a short half-life still limited its use.",
"   </p>",
"   <p>",
"    The biodegradable long-acting gelatin sponge (Gelfoam, Upjohn, Kalamazoo, MI) is commonly used for patients with nonvariceal GI bleeding. It causes hemostasis upon contact when injected into a vessel. Gelfoam comes as a powder or as small blocks that are cut to the desired size. The latter is preferred since the powdered form is more likely to lead to bowel infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/18\">",
"     18",
"    </a>",
"    ]. Gelfoam blocks can produce temporary (7- to 21-day) or permanent occlusion of the targeted artery.",
"   </p>",
"   <p>",
"    An example of a permanent embolic agent is polyvinyl alcohol (Ivalon, Fabco, New London, CT), which is available as small microspheres or sheets. Permanent occlusion is achieved through mechanical impaction. Permanent agents are used when bleeding occurs from a lesion that is not expected to heal spontaneously, such as a tumor, aneurysm, or arteriovenous communication.",
"   </p>",
"   <p>",
"    Liquid agents have also been used for embolization. These agents include N-butyl 2-cyanoacrylate (NBCA) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/19-23\">",
"     19-23",
"    </a>",
"    ] and ethylene-vinyl alcohol copolymer (Onyx, Micro Therapeutics, Inc, Irvine, CA). Once delivered, these agents solidify, leading to embolization. A potential advantage of NBCA is that the time required for embolization is shorter than that with other agents [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/22\">",
"     22",
"    </a>",
"    ]. However, its use requires significant training and has been associated with bowel ischemia, reflux of the glue into other vessels, and nontarget embolization [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/6\">",
"     6",
"    </a>",
"    ]. Ethylene-vinyl alcohol is nonadhesive (so there is no risk of it polymerizing to the catheter tip), has high radiopacity, and has long solidification periods that allow for more controllable and predictable embolization [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/6\">",
"     6",
"    </a>",
"    ]. However, the vehicle,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/22/33123?source=see_link\">",
"     dimethylsulfoxide",
"    </a>",
"    (DMSO) can cause severe vasospasm if injected too rapidly and it requires special DMSO-compatible catheters. Finally, available preparations of ethylene-vinyl alcohol are significantly more expensive than alternative embolic materials.",
"   </p>",
"   <p>",
"    Mechanical blocking agents, such as steel coils, platinum microcoils, balloons, and silk thread, can also be used when permanent occlusion of an artery is required. These agents are best suited for patients with bleeding from varices, a large visceral artery, or the gastroduodenal artery, which supplies a region with a rich dual blood supply. Coils typically are placed both proximal and distal to sites of bleeding in order to prevent back bleeding when collateral vessels are present.",
"   </p>",
"   <p>",
"    Detachable balloons are seldom used for GI bleeding; however, nondetachable balloons can be used as a temporary measure prior to surgery. In some patients, combinations of agents are used to produce both distal and proximal occlusion of a bleeding artery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Embolic agents are best delivered via an end-hole catheter that is inserted through a vascular sheath. An initial angiogram must be performed to confirm the bleeding site and to identify anomalous or variant vascular anatomy. The catheter should be inserted into the selected artery in order to avoid reflux of embolic materials into undesired vessels.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     Vasopressin",
"    </a>",
"    should",
"    <strong>",
"     not",
"    </strong>",
"    be infused immediately after embolization as it may compromise collateral circulation resulting in intestinal infarction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/7/30841?source=see_link&amp;anchor=H8#H8\">",
"     \"Approach to resuscitation and diagnosis of acute lower gastrointestinal bleeding in the adult patient\", section on 'Angiography'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Microcoils have become the preferred agent for embolizing bleeding vessels and are simply deployed via a microcatheter to the site of bleeding. Similarly, polyvinyl alcohol is delivered via a peripherally-placed catheter.",
"   </p>",
"   <p>",
"    In order to use gelating sponge, blocks of gelatin sponge are cut into small 2 to 3 mm strips, inserted into a tuberculin syringe, mixed with saline and contrast material, and administered into the percutaneously placed catheter under direct fluoroscopic vision. The effect upon blood flow is immediately evaluated fluoroscopically; the procedure can be repeated until arterial occlusion occurs and bleeding stops. Care should be used while placing the catheter selectively into peripheral arteries since reflux of the gelatin sponge can occur during diastole or if the material is injected too vigorously, leading to undesired occlusion of additional arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complications of embolization include those associated with arteriography itself (eg, hematomas, arterial thrombosis, dissection, embolism, and pseudoaneurysm formation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/24\">",
"     24",
"    </a>",
"    ]), and bowel infarction. In a systematic review that included 927 patients undergoing embolization for upper GI bleeding, complications occurred in 5 to 9 percent of patients, depending upon the type of bleeding (luminal or transpapillary), with ischemia and infarction accounting for the majority of complications [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fortunately, the luminal GI tract has a rich collateral blood supply, so bowel infarction is unlikely to occur in young patients who have not had previous bowel surgery. Age, vascular disease,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    use, and previous bowel surgery reduce this collateral supply, especially to the colon. Superselective catheter deployment decreases the risk of bowel infarction, but may not always be technically feasible. In addition, despite superselective catheter deployment, bowel wall necrosis may occur if vasopressin therapy is necessary following embolization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H331712\">",
"    <span class=\"h2\">",
"     Choice of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice between",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    and embolization should be individualized for each patient, taking into account angiographer experience. Vasopressin is easy to use and may be particularly helpful in hemorrhagic gastropathy because of its diffuse peripheral vasoconstrictive effect [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, patients with bleeding duodenal ulcers are relatively unresponsive to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    infusion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/27\">",
"     27",
"    </a>",
"    ]. This is due in part to the dual blood supply of the duodenum, the inflammatory reaction produced by penetrating ulcers, and the frequent involvement of large vessels (such as the gastroduodenal artery), which do not constrict in response to vasopressin. Interventions, such as surgery or angiography, are indicated in patients who have active bleeding from a duodenal ulcer that is not stopped or slowed down significantly with endoscopic therapy, while repeat endoscopy and retreatment of the bleeding source can be performed for lesions that are initially controlled by endoscopic therapy. The patient is usually referred for surgery if the bleeding persists or rebleeding occurs after two therapeutic endoscopies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24826?source=see_link\">",
"     \"Overview of the treatment of bleeding peptic ulcers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61544525\">",
"    <span class=\"h2\">",
"     Management of rebleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rebleeding among patients who initially achieve hemostasis following angiographic therapy may exceed 50 percent with some therapies. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Outcomes'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Treatment options in patients with rebleeding include attempts at endoscopic therapy, repeated angiographic therapy, and surgery. The choice of procedure will depend upon the magnitude of the bleed, the likelihood of its being amenable to a specific therapy, and whether the patient is a surgical candidate.",
"   </p>",
"   <p>",
"    Patients with rebleeding following",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    infusion can be treated with a repeat infusion or embolization. If embolic material is to be used, the midsized rather than large arteries should be targeted to allow adequate collateral blood supply to develop around the site of occlusion.",
"   </p>",
"   <p>",
"    Success rates of 85 to 95 percent for managing gastric and duodenal hemorrhage have been reported when failed",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    infusion is followed by embolization [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/11,28\">",
"     11,28",
"    </a>",
"    ]. However, infusion therapy following failed embolization carries a greater risk of infarction and necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiographic therapy for gastrointestinal (GI) bleeding is initially successful in most patients in whom it is technically feasible, but rebleeding is common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H332355\">",
"    <span class=\"h2\">",
"     Efficacy of intra-arterial vasopressin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The success of intra-arterial",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    infusion varies with the site of bleeding. In patients with lower gastrointestinal bleeding, intra-arterial infusion of vasopressin will lead to the cessation of bleeding in approximately 80 to 90 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. However, not all patients undergoing angiography will have a bleeding site identified, and even if a bleeding site is identified, intra-arterial vasopressin infusion may not be technically possible, or bleeding may recur once the infusion is stopped (seen in 5 to 50 percent of patients).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 50 patients with massive lower GI bleeding, a bleeding site was identified in 36 (72 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/29\">",
"       29",
"      </a>",
"      ]. Of the 36 with a bleeding site,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      infusion was not possible in 14 (39 percent) due to an inability to maintain selective catheterization of the vessel, the presence of severe ischemic heart disease, or because the bleeding stopped during angiography. Thus, vasopressin was only used in 22 of 50 patients. While vasopressin was initially successful in 20 patients (91 percent of those receiving vasopressin and 40 percent of those presenting with lower GI bleeding), rebleeding occurred in 10 patients (50 percent) once the vasopressin was stopped. Nevertheless, the angiographic intervention permitted elective rather than emergency subtotal colectomy in many instances, resulting in an operative morbidity of only 9 percent (compared with 37 percent in patients undergoing emergency subtotal colectomy in other series).",
"     </li>",
"     <li>",
"      In a second report,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      infusion controlled bleeding in 80 to 90 percent of patients with diverticulosis, the most common cause of massive lower GI bleeding [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/31\">",
"       31",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38679?source=see_link\">",
"       \"Colonic diverticular bleeding\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Success rates in patients with upper GI bleeding vary depending upon the site of bleeding. In patients with gastric bleeding, selective angiography identifies a point of extravasation in approximately 60 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/27\">",
"     27",
"    </a>",
"    ]. In those who receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    , initial success rates are approximately 70 to 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/11,28,32,33\">",
"     11,28,32,33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 50 patients with gastric mucosal hemorrhage,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      infusion was possible in 37 patients (74 percent), with control of bleeding in 31 (84 percent of those treated with vasopressin, 62 percent of the entire cohort) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/32\">",
"       32",
"      </a>",
"      ]. The remaining 13 patients did not receive vasopressin because it was not technically feasible to catheterize the appropriate artery (8 patients) or because of comorbid illnesses that precluded treatment with vasopressin (5 patients). Rebleeding occurred in two of the patients whose bleeding was initially controlled (6 percent). Other studies have suggested rebleeding rates of approximately 16 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/33,34\">",
"       33,34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 194 patients with gastric bleeding who were treated with intra-arterial",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      , the initial rate of bleeding control was 73 percent, irrespective of whether the infusion was administered via the left gastric or celiac artery [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/11\">",
"       11",
"      </a>",
"      ]. Bleeding recurred in 18 percent, 36 percent of whom were successfully managed either by a repeat infusion of vasopressin or by embolization.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     Vasopressin",
"    </a>",
"    appears less likely to control bleeding in patients with bleeding from the pylorus or duodenum:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 46 patients with pyloroduodenal bleeding, bleeding was controlled with intra-arterial",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      in 15 (33 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/35\">",
"       35",
"      </a>",
"      ]. However, rebleeding occurred in 5 (33 percent). Thus, bleeding was controlled in only 10 of 46 patients (22 percent).",
"     </li>",
"     <li>",
"      In a second study that included 15 patients with pyloroduodenal hemorrhage, 13 were treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      , with bleeding control achieved in 8 of the 13 (62 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61543683\">",
"    <span class=\"h2\">",
"     Efficacy of embolization",
"    </span>",
"    &nbsp;&mdash;&nbsp;When technically feasible, embolization is initially successful in treating approximately 95 percent of patients with GI bleeding. However, as is seen with intra-arterial",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    , rebleeding is common (9 to 56 percent, depending upon the bleeding site) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/25,36-40\">",
"     25,36-40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Systematic reviews have evaluated the efficacy of embolization for upper GI bleeding:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of 15 studies with 819 patients with upper GI bleeding, endovascular embolization with coils, polyvinyl alcohol particles, blood clots, gelatin sponge, or N-butyl 2-cyanoacrylate (NBCA) was technically successful in 762 patients (93 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/36\">",
"       36",
"      </a>",
"      ]. Technical failures were due to difficult vascular anatomy, arterial dissection, vasospasm, false-negative read of an angiogram, multiple bleeding sites, and bleeding from a tumor. Of those who underwent technically successful embolization, 549 (67 percent) responded well clinically with cessation of bleeding. Rebleeding occurred in 33 percent, though half responded to repeat embolization.",
"     </li>",
"     <li>",
"      A second review included 35 studies with 927 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/25\">",
"       25",
"      </a>",
"      ]. Studies were divided into those that examined primary upper GI tract (luminal) hemorrhage, transpapillary hemorrhage (hemobilia or hemosuccus pancreaticus), or both. Technical success rates ranged from 52 to 100 percent. The pooled mean technical success rates for studies with luminal hemorrhage, transpapillary hemorrhage, or both were 84, 93, and 93 percent, respectively, with clinical success rates of 67, 89, and 64 percent, respectively. Rebleeding rates were 27, 9, and 26 percent, respectively. This review suggests that angiographic embolization may be particularly useful in patients with transpapillary hemorrhage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Factors associated with failed embolization for upper GI bleeding include multiorgan failure, anticoagulant use, corticosteroid use, pre-embolization vasopressor use, bleeding subsequent to trauma or invasive procedures, longer time to angiography, previous surgery, and embolization using coils alone or coils with another embolic agent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/25,36,41\">",
"     25,36,41",
"    </a>",
"    ]. However, treatment failure does not appear to be associated with empiric embolization of endoscopically identified bleeding sources [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H331530\">",
"     'Lesion localization'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Initial success rates with embolization for the treatment of lower GI bleeding are also high:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a summary of 15 studies with 309 patients, embolization using polyvinyl alcohol, coils, or gelatin sponge was technically feasible in 82 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/44\">",
"       44",
"      </a>",
"      ]. Of those who were embolized, 95 percent of patients had immediate hemostasis and 76 percent were free of bleeding within 30 days. Minor ischemic episodes were noted in ten percent, with major ischemic episodes being reported in 2 percent.",
"     </li>",
"     <li>",
"      A subsequent study examined 78 patients with 83 episodes of lower GI bleeding [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/45\">",
"       45",
"      </a>",
"      ]. Angiography identified active bleeding in 40 episodes (48 percent) and embolization was carried out for 38 episodes (46 percent; 37 episodes with active bleeding on angiography and one without active bleeding).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, embolization for lower GI bleeding has been associated with rebleeding rates of 22 to 56 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/45-49\">",
"     45-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    NBCA embolization has also been used in the treatment of lower GI bleeding. In a study with 27 patients with lower GI bleeding who underwent NBCA embolization, immediate hemostasis was achieved in all 27 (one patient was also treated with a microcoil) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/50\">",
"     50",
"    </a>",
"    ]. Rebleeding occurred in four patients (15 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6379204\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Angiographic control of gastrointestinal (GI) bleeding is indicated for patients with upper or lower GI bleeding who fail to respond to medical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      endoscopic therapy. In patients with upper GI bleeding, angiographic control of bleeding is generally considered if endoscopic attempts at therapy have failed. In patients with lower GI bleeding, angiographic control of bleeding is used as an alternative to surgery in hemodynamically unstable patients with severe bleeding or for patients with ongoing or recurrent bleeding following attempts to control the bleeding endoscopically. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Angiographic therapies include the infusion of vasoconstricting medications or the delivery of agents to mechanically occlude the vascular supply of the bleeding lesion (embolization). (See",
"      <a class=\"local\" href=\"#H331951\">",
"       'Angiographic therapies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       Vasopressin",
"      </a>",
"      causes generalized vasoconstriction via a direct action upon vessel walls, especially the arterioles, capillaries, and venules. The goal is for the decrease in perfusion pressure to permit stable clot formation at the bleeding site. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Intra-arterial vasopressin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      causes peripheral vasoconstriction, it should be used with caution in patients with coronary artery disease, congestive cardiomyopathy, severe hypertension, or severe peripheral vascular disease. It can also cause arrhythmias and water retention leading to hyponatremia. (See",
"      <a class=\"local\" href=\"#H72428395\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Agents used for embolization include biodegradable gelatin sponge, polyvinyl alcohol particles, liquid agents, such as N-butyl 2-cyanoacrylate, and metallic coils. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Embolization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The complications of embolization include those associated with arteriography itself (eg, hematomas, arterial thrombosis, dissection, embolism, and pseudoaneurysm formation [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24616/abstract/24\">",
"       24",
"      </a>",
"      ]), and bowel infarction. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial hemostasis may be achieved in up to 95 percent of patients in whom angiographic therapy is technically feasible, but rebleeding is a common problem, occurring in up to 56 percent of patients. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/1\">",
"      Wee E. Management of nonvariceal upper gastrointestinal bleeding. J Postgrad Med 2011; 57:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/2\">",
"      Edelman DA, Sugawa C. Lower gastrointestinal bleeding: a review. Surg Endosc 2007; 21:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/3\">",
"      Anthony T, Penta P, Todd RD, et al. Rebleeding and survival after acute lower gastrointestinal bleeding. Am J Surg 2004; 188:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/4\">",
"      Millward SF. ACR Appropriateness Criteria on treatment of acute nonvariceal gastrointestinal tract bleeding. J Am Coll Radiol 2008; 5:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/5\">",
"      Zuccaro G Jr. Management of the adult patient with acute lower gastrointestinal bleeding. American College of Gastroenterology. Practice Parameters Committee. Am J Gastroenterol 1998; 93:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/6\">",
"      Loffroy RF, Abualsaud BA, Lin MD, Rao PP. Recent advances in endovascular techniques for management of acute nonvariceal upper gastrointestinal bleeding. World J Gastrointest Surg 2011; 3:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/7\">",
"      Padia SA, Geisinger MA, Newman JS, et al. Effectiveness of coil embolization in angiographically detectable versus non-detectable sources of upper gastrointestinal hemorrhage. J Vasc Interv Radiol 2009; 20:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/8\">",
"      Darcy M. Treatment of lower gastrointestinal bleeding: vasopressin infusion versus embolization. J Vasc Interv Radiol 2003; 14:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/9\">",
"      Funaki B. Endovascular intervention for the treatment of acute arterial gastrointestinal hemorrhage. Gastroenterol Clin North Am 2002; 31:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/10\">",
"      Rosen RJ, Sanchez G. Angiographic diagnosis and management of gastrointestinal hemorrhage. Current concepts. Radiol Clin North Am 1994; 32:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/11\">",
"      Eckstein MR, Kelemouridis V, Athanasoulis CA, et al. Gastric bleeding: therapy with intraarterial vasopressin and transcatheter embolization. Radiology 1984; 152:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/12\">",
"      Sherman LM, Shenoy SS, Cerra FB. Selective intra-arterial vasopressin: clinical efficacy and complications. Ann Surg 1979; 189:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/13\">",
"      Walker TG, Waltman AC. Vasoconstrictive infusion therapy for management of arterial gastrointestinal hemorrhage. Semin Intervent Radiol 1988; 5:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/14\">",
"      Motsay GJ, Sutherland DE, Simmons RL. Reversible pedal ischemia following intra-arterial infusion of vasopressin at a high dosage level required for control of massive bleeding from the small bowel: a case report. Ann Surg 1973; 178:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/15\">",
"      Alves M, Patel V, Douglas E, Deutsch E. Gastric infarction: a complication of selective vasopressin infusion. Dig Dis Sci 1979; 24:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/16\">",
"      Walker TG. Acute gastrointestinal hemorrhage. Tech Vasc Interv Radiol 2009; 12:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/17\">",
"      R&ouml;sch J, Dotter CT, Brown MJ. Selective arterial embolization. A new method for control of acute gastrointestinal bleeding. Radiology 1972; 102:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/18\">",
"      R&ouml;sch J, Keller FS, Kozak B, et al. Gelfoam powder embolization of the left gastric artery in treatment of massive small-vessel gastric bleeding. Radiology 1984; 151:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/19\">",
"      Loffroy R, Guiu B, D'Athis P, et al. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol 2009; 7:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/20\">",
"      Park JH, Kim HC, Chung JW, et al. Transcatheter arterial embolization of arterial esophageal bleeding with the use of N-butyl cyanoacrylate. Korean J Radiol 2009; 10:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/21\">",
"      Lee CW, Liu KL, Wang HP, et al. Transcatheter arterial embolization of acute upper gastrointestinal tract bleeding with N-butyl-2-cyanoacrylate. J Vasc Interv Radiol 2007; 18:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/22\">",
"      Toyoda H, Nakano S, Kumada T, et al. Estimation of usefulness of N-butyl-2-cyanoacrylate-lipiodol mixture in transcatheter arterial embolization for urgent control of life-threatening massive bleeding from gastric or duodenal ulcer. J Gastroenterol Hepatol 1996; 11:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/23\">",
"      Frodsham A, Berkmen T, Ananian C, Fung A. Initial experience using N-butyl cyanoacrylate for embolization of lower gastrointestinal hemorrhage. J Vasc Interv Radiol 2009; 20:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/24\">",
"      Silverstein FE, Gilbert DA, Tedesco FJ, et al. The national ASGE survey on upper gastrointestinal bleeding. I. Study design and baseline data. Gastrointest Endosc 1981; 27:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/25\">",
"      Mirsadraee S, Tirukonda P, Nicholson A, et al. Embolization for non-variceal upper gastrointestinal tract haemorrhage: a systematic review. Clin Radiol 2011; 66:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/26\">",
"      Feldman L, Greenfield AJ, Waltman AC, et al. Transcatheter vessel occlusion: angiographic results versus clinical success. Radiology 1983; 147:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/27\">",
"      Waltman AC. Transcatheter embolization versus vasopressin infusion for the control of arteriocapillary gastrointestinal bleeding. Cardiovasc Intervent Radiol 1980; 3:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/28\">",
"      Clark RA, Colley DP, Eggers FM. Acute arterial gastrointestinal hemorrhage: efficacy of transcatheter control. AJR Am J Roentgenol 1981; 136:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/29\">",
"      Browder W, Cerise EJ, Litwin MS. Impact of emergency angiography in massive lower gastrointestinal bleeding. Ann Surg 1986; 204:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/30\">",
"      Cherian MP, Mehta P, Kalyanpur TM, et al. Arterial interventions in gastrointestinal bleeding. Semin Intervent Radiol 2009; 26:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/31\">",
"      Baum S, R&ouml;sch J, Dotter CT, et al. Selective mesenteric arterial infusions in the management of massive diverticular hemorrhage. N Engl J Med 1973; 288:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/32\">",
"      Athanasoulis CA, Baum S, Waltman AC, et al. Control of acute gastric mucosal hemorrhage. Intra-arterial infusion of posterior pituitary extract. N Engl J Med 1974; 290:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/33\">",
"      Athanasoulis CA, Waltman AC, Novelline RA, et al. Angiography: its contribution to the emergency management of gastrointestinal hemorrhage. Radiol Clin North Am 1976; 14:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/34\">",
"      Conn HO, Ramsby GR, Storer EH, et al. Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology 1975; 68:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/35\">",
"      Waltman AC, Greenfield AJ, Novelline RA, Athanasoulis CA. Pyloroduodenal bleeding and intraarterial vasopressin: clinical results. AJR Am J Roentgenol 1979; 133:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/36\">",
"      Loffroy R, Rao P, Ota S, et al. Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol 2010; 33:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/37\">",
"      Ripoll C, Ba&ntilde;ares R, Beceiro I, et al. Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol 2004; 15:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/38\">",
"      De Wispelaere JF, De Ronde T, Trigaux JP, et al. Duodenal ulcer hemorrhage treated by embolization: results in 28 patients. Acta Gastroenterol Belg 2002; 65:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/39\">",
"      Duvnjak S, Andersen PE. The effect of transcatheter arterial embolisation for nonvariceal upper gastrointestinal bleeding. Dan Med Bull 2010; 57:A4138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/40\">",
"      Kickuth R, Rattunde H, Gschossmann J, et al. Acute lower gastrointestinal hemorrhage: minimally invasive management with microcatheter embolization. J Vasc Interv Radiol 2008; 19:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/41\">",
"      Lundgren JA, Matsushima K, Lynch FC, et al. Angiographic embolization of nonvariceal upper gastrointestinal bleeding: predictors of clinical failure. J Trauma 2011; 70:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/42\">",
"      Ichiro I, Shushi H, Akihiko I, et al. Empiric transcatheter arterial embolization for massive bleeding from duodenal ulcers: efficacy and complications. J Vasc Interv Radiol 2011; 22:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/43\">",
"      Aina R, Oliva VL, Therasse E, et al. Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 2001; 12:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/44\">",
"      Weldon DT, Burke SJ, Sun S, et al. Interventional management of lower gastrointestinal bleeding. Eur Radiol 2008; 18:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/45\">",
"      Gillespie CJ, Sutherland AD, Mossop PJ, et al. Mesenteric embolization for lower gastrointestinal bleeding. Dis Colon Rectum 2010; 53:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/46\">",
"      Tan KK, Wong D, Sim R. Superselective embolization for lower gastrointestinal hemorrhage: an institutional review over 7 years. World J Surg 2008; 32:2707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/47\">",
"      Bandi R, Shetty PC, Sharma RP, et al. Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Interv Radiol 2001; 12:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/48\">",
"      DeBarros J, Rosas L, Cohen J, et al. The changing paradigm for the treatment of colonic hemorrhage: superselective angiographic embolization. Dis Colon Rectum 2002; 45:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/49\">",
"      Neuman HB, Zarzaur BL, Meyer AA, et al. Superselective catheterization and embolization as first-line therapy for lower gastrointestinal bleeding. Am Surg 2005; 71:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24616/abstract/50\">",
"      Huang CC, Lee CW, Hsiao JK, et al. N-butyl cyanoacrylate embolization as the primary treatment of acute hemodynamically unstable lower gastrointestinal hemorrhage. J Vasc Interv Radiol 2011; 22:1594.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2540 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-40244E071D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24616=[""].join("\n");
var outline_f24_2_24616=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6379204\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H331530\">",
"      LESION LOCALIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H331951\">",
"      ANGIOGRAPHIC THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Intra-arterial vasopressin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H72428466\">",
"      - Technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H72428395\">",
"      - Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Embolization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H331712\">",
"      Choice of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H61544525\">",
"      Management of rebleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H332355\">",
"      Efficacy of intra-arterial vasopressin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H61543683\">",
"      Efficacy of embolization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6379204\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8410?source=related_link\">",
"      Angiodysplasia of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28538?source=related_link\">",
"      Approach to acute upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/7/30841?source=related_link\">",
"      Approach to resuscitation and diagnosis of acute lower gastrointestinal bleeding in the adult patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38679?source=related_link\">",
"      Colonic diverticular bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24826?source=related_link\">",
"      Overview of the treatment of bleeding peptic ulcers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_2_24617="Chapter 3A: Cell model for proximal transport";
var content_f24_2_24617=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 3A: Cell model for proximal transport",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24617/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24617/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24617/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24617/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24617/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/2/24617/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/2/24617/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/2/24617/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 29, 2001.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluid filtered at the glomerulus enters the proximal tubule where about 55 to 60 percent of the filtrate is normally reabsorbed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/1\">",
"     1",
"    </a>",
"    ]. The primary event in proximal tubular function is the active transport of Na+, which then allows water and many of the other filtered solutes to be reabsorbed passively in a reabsorbate that is isosmotic to plasma. In addition, some solutes are secreted rather than reabsorbed in this segment, including hydrogen ions (H+) and organic anions and cations.",
"   </p>",
"   <p>",
"    Although the proximal tubule plays a major role in solute transport, the degree of reabsorption of individual solutes is not uniform. Almost all of the filtered glucose and amino acids are reabsorbed in this segment, but only about 90 percent of the HCO3-, 65 percent of the Na+, and 55 percent of the Cl- (",
"    <a class=\"graphic graphic_figure graphicRef80438 \" href=\"UTD.htm?9/31/9726\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/1\">",
"     1",
"    </a>",
"    ]. This chapter will review the basic aspects of how the proximal tubule selectively performs these functions as well as some of the clinical implications of the relationship between the reabsorption of Na+ and that of the other solutes in the filtrate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proximal tubule has a convoluted segment, which begins at the glomerulus, and then a straight segment (pars recta), which ends in the outer medulla in the descending limb of the loop of Henle. However, closer examination has revealed the presence of three distinct proximal segments with different cell types: S1 in the early convoluted segment; S2 in the late convoluted segment and early pars recta; and S3 in the remainder of the pars recta (",
"    <a class=\"graphic graphic_figure graphicRef58220 \" href=\"UTD.htm?22/29/23006\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/2\">",
"     2",
"    </a>",
"    ]. These cell types can be isolated in relative purity via the use of monoclonal antibodies directed against cell surface peptidases uniquely expressed in each type, such as leucine aminopeptidase in the S3 segment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cells in the different proximal segments are, to some degree, associated with different functional characteristics. The S1 segment, for example, is a high-capacity site that plays a larger quantitative role in Na+ and HCO3- reabsorption than the later segments [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/1\">",
"     1",
"    </a>",
"    ]. Both an increased number of transporters in the luminal membrane and a greater surface area available for reabsorption play a contributory role. In comparison, tubular secretion by the organic anion and cation secretory pumps is most prominent in the S2 segment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CELL MODEL FOR PROXIMAL TRANSPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomy of the proximal tubule is similar to that of other transporting epithelia (",
"    <a class=\"graphic graphic_figure graphicRef67126 \" href=\"UTD.htm?29/36/30286\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The cells have two membranes with different permeability and transport characteristics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The luminal (or apical) membrane, which separates the cell from the tubular lumen, contains a variety of transmembrane protein carriers that facilitate solute entry into the cell and, to a lesser degree, solute secretion into the lumen [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The basolateral (or peritubular) membrane separates the cell from the interstitium and peritubular capillary. This membrane contains the Na+-K+-ATPase pump, as well as transporters and channels that allow reabsorbed solutes to be returned to the systemic circulation. As will be seen, the Na+-K+-ATPase pump indirectly provides the energy that allows virtually all of the transport proteins to passively translocate filtered solutes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The proximal tubular cells are separated by an intercellular space, which is open both at the capillary end and to a lesser degree at the luminal end across the tight junction. The tight junction is composed of protein molecules that bring adjacent cells into apposition; it also serves as a boundary between the luminal and basolateral membranes, preventing the lateral diffusion of membrane proteins from one membrane to the other [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The proximal tubule can reabsorb more than 100",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    in subjects with normal renal function (55 to 60 percent of a daily filtration rate of 150 to 180 liters). It is well suited for this task because of a series of adaptations, each of which facilitates net reabsorption of the filtrate:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The luminal membrane has microvilli which increase the surface area available for reabsorption. In addition, the microvilli have a brush border that contains specific carrier proteins as well as an enzyme, carbonic anhydrase, which plays an important role in HCO3- reabsorption (see Chap. 11).",
"     </li>",
"     <li>",
"      Solute reabsorption creates an osmotic gradient that allows water to be reabsorbed in part across the cells. This process can occur because both the luminal and basolateral membranes are relatively water permeable due to the presence of water channels within the membrane [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/7-9\">",
"       7-9",
"      </a>",
"      ]; these water channels, called aquaporin-1, appear to be similar to those in red cells [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/8\">",
"       8",
"      </a>",
"      ]. Targeted disruption of the genes for these channels results in the inability to reabsorb fluid within the proximal tubules [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/10\">",
"       10",
"      </a>",
"      ]. In comparison, the luminal membranes of the ascending limb of the loop of Henle and the entire distal nephron largely lack water channels and do not allow osmotic water transport in the basal state (see Chaps. 4 and 5). Antidiuretic hormone, however, can increase the water permeability of the collecting tubule cells by causing a different type of preformed water channels, called aquaporin-2, in the cytosol to move to and fuse with the luminal membrane (see Chap. 6); this process is one of the essential steps both in distal water reabsorption and in the formation of a concentrated urine.",
"     </li>",
"     <li>",
"      The preferential reabsorption of HCO3- in the early proximal tubule results in osmotic water transport and a subsequent rise in the tubular fluid Cl- concentration (",
"      <a class=\"graphic graphic_figure graphicRef80438 \" href=\"UTD.htm?9/31/9726\">",
"       figure 1",
"      </a>",
"      ). As will be discussed below, this Cl- gradient is sufficient to allow as much as one-third of proximal NaCl and water reabsorption to occur passively through the tight junction [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. This capacity for passive transport is reflected in the observation that, despite the high rate of total reabsorption, Na+-K+-ATPase activity in the proximal tubule is much lower than that in the thick ascending limb or distal tubule [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Substantial passive reabsorption can occur because the tight junction of the proximal tubule is relatively \"leaky\" in comparison to other nephron segments [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/6\">",
"       6",
"      </a>",
"      ]. On freeze-fracture electron microscopy, the tight junction has a strand-like appearance. The proximal tubule has only one strand versus up to eight in tight epithelia, such as the distal nephron [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/6\">",
"       6",
"      </a>",
"      ]. Thus, transport through the paracellular pathway in the proximal tubule is a low-resistance route in comparison to having to traverse both the luminal and basolateral membranes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, filtered Na+ passively enters the cell across the luminal membrane and is then actively transported by the Na+-K+-ATPase pump into the intercellular space. The removal of Na+ and other solutes from the lumen initially lowers the luminal osmolality, creating an osmotic gradient of up to 15 mmHg that promotes the reabsorption of H2O [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Water movement is also promoted by an additional factor: the preferential reabsorption of NaHCO3 in the early proximal tubule leads to an elevation in the tubular fluid Cl- concentration; this makes the effective luminal osmolality even lower, since the tight junction is relatively permeable to Cl-, which therefore functions as an ineffective osmole (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Passive mechanisms of proximal transport'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reabsorbate that accumulates in the intercellular space can then enter the peritubular capillary and be returned to the systemic circulation or can leak back into the lumen across the tight junction. As will be seen, net proximal Na+ and water reabsorption is affected by multiple factors including filtered solutes that are reabsorbed with Na+, peritubular capillary hemodynamics, and neurohumoral factors such as angiotensin II, norepinephrine, and dopamine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cell entry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Luminal Na+ must enter the cells before it can be reabsorbed. The primary step in this process is the Na+-K+-ATPase pump in the basolateral membrane, which has two functions that create a favorable electrochemical gradient for passive Na+ entry into the cells (",
"    <a class=\"graphic graphic_figure graphicRef79776 \" href=\"UTD.htm?19/6/19566\">",
"     figure 4",
"    </a>",
"    ). First, the pump maintains the effective cell Na+ concentration at about 20 to 30",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    by transporting Na+ out of the cell; this is well below the value of 145",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in the filtrate [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/16\">",
"     16",
"    </a>",
"    ]. Second, the pump contributes to the development of a cell interior negative potential by promoting the net loss of cations; this results both from the 3Na+:2K+ stoichiometry of the pump and from the subsequent back diffusion of this K+ out of the cell through ATP-sensitive K+ channels in the basolateral membrane&dagger; [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;&dagger;The activity of the Na+-K+-ATPase pump and the K+ channel appropriately vary in parallel. A reduction in pump activity, due for example to decreased Na+ reabsorption, results in ATP accumulation in the cell which then downregulates the ATP-sensitive K+ channels [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/18\">",
"     18",
"    </a>",
"    ]. Less K+ exit through these channels is required in this setting, since there is less K+ entry via the Na+-K+-ATPase pump.",
"   </p>",
"   <p>",
"    The net effect is a highly favorable electrochemical gradient that promotes passive Na+ entry into the cells. This process, however, must occur via a transmembrane carrier or channel, since ions are unable to freely cross the lipid bilayer of the cell membranes. In the proximal tubule, Na+ movement across the luminal membrane is partially linked to the cotransport of other solutes, as specific Na+-glucose, Na+-amino acid, and Na+-phosphate carrier proteins are present in the brush border vesicles in the luminal membrane (",
"    <a class=\"graphic graphic_figure graphicRef79776 \" href=\"UTD.htm?19/6/19566\">",
"     figure 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. Both sites must be occupied on the carrier for cotransport to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Na+ entry also occurs by",
"    <strong>",
"     countertransport",
"    </strong>",
"    &nbsp;(or antiport) with H+, as the carrier promotes both Na+ reabsorption and H+ secretion into the lumen (the latter step leading primarily to HCO3- reabsorption) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12762?source=see_link\">",
"     \"Chapter 11A: Renal hydrogen excretion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As an example, one experiment used to document Na+-dependent glucose reabsorption is illustrated by the study of proximal brush border vesicles in Figure 5 (",
"    <a class=\"graphic graphic_figure graphicRef70371 \" href=\"UTD.htm?35/26/36269\">",
"     figure 5",
"    </a>",
"    ). The glucose concentration was the same in the bath and the vesicle, leading to no glucose uptake into the vesicle in the absence of a transvesicle Na+ gradient. However, glucose uptake was markedly stimulated when the bath Na+ concentration was elevated to 10 times that in the vesicle.",
"   </p>",
"   <p>",
"    The mechanism by which coupled transport occurs is incompletely understood. The binding of the cotransported solute (as with glucose) appears to lead to a conformational change in the transport protein that results in opening of the gate for a transmembrane Na+ pathway. As a result, Na+ crosses the membrane down its favorable inward gradient and flow of the cotransported solute is in some way linked to that of Na+ [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/25\">",
"     25",
"    </a>",
"    ]; the helical structure of these transporters appears to facilitate this process [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/26\">",
"     26",
"    </a>",
"    ]. This passive process is called secondary active transport, since the energy is indirectly provided by the Na+-K+-ATPase pump.",
"   </p>",
"   <p>",
"    In addition to this primary role for Na+, there is also evidence that the other solutes increase the reabsorption of Na+. As an example, the removal of glucose, amino acids,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bicarbonate from the luminal fluid markedly impairs proximal Na+ reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Two factors may contribute to this effect: (1) attachment of the cotransported solute to the carrier may increase its affinity for Na+; and (2) glucose and bicarbonate are effective osmoles that, as they accumulate in the intercellular space, promote the passive reabsorption of NaCl and H2O across the tight junction (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Passive mechanisms of proximal transport'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Movement into the intercellular space",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the basolateral membrane, Na+ that has entered the cell must be transported into the intercellular space against electrical and concentration gradients (",
"    <a class=\"graphic graphic_figure graphicRef79776 \" href=\"UTD.htm?19/6/19566\">",
"     figure 4",
"    </a>",
"    ). The energy required for this process is derived from the hydrolysis of ATP by the Na+-K+-ATPase pump. This pump, which is also essential for Na+ reabsorption in other nephron segments [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/13\">",
"     13",
"    </a>",
"    ], transports Na+ out of the cell and K+ into the cell in a 3:2, not a 1:1, ratio (",
"    <a class=\"graphic graphic_figure graphicRef79776 \" href=\"UTD.htm?19/6/19566\">",
"     figure 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Solutes other than Na+ move passively across the basolateral membrane, again by carrier-mediated transport. As depicted in figure 4 (",
"    <a class=\"graphic graphic_figure graphicRef79776 \" href=\"UTD.htm?19/6/19566\">",
"     figure 4",
"    </a>",
"    ), for example, carbonic acid (H2CO3) within the cell dissociates into H+ &nbsp;and HCO3- ions. The former is secreted into the lumen by the Na+-H+ antiporter, whereas HCO3- is returned to the systemic circulation by a 3HCO3-",
"    <span class=\"nowrap\">",
"     /1Na+",
"    </span>",
"    carrier in the basolateral membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The energy for this process is derived from a more complex form of secondary active transport. The central step is again the Na+-K+-ATPase pump, which pumps K+ into the cell, thereby raising the cell K+ concentration. The latter change promotes passive K+ exit from the cell via K+ channels in the basolateral membrane, a process that makes the cell interior negative with respect to the interstitium; this potential then drives the net transfer of negative charge out of the cell via the 3HCO3-",
"    <span class=\"nowrap\">",
"     /1Na+",
"    </span>",
"    carrier.",
"   </p>",
"   <p>",
"    Note that K+ entry into the cells via the Na+-K+-ATPase pump and the backleak of this K+ out of the cells varies in parallel with Na+ transport. The link between these processes appears to be ATP, which normally inhibits the basolateral K+ channels [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/31\">",
"     31",
"    </a>",
"    ]. If, for example, Na+ reabsorption rises, the associated elevation in Na+-K+-ATPase activity will lower cell ATP stores, thereby removing the inhibitory effect of ATP and increasing the number of open K+ channels in the basolateral membrane. Thus, the extra K+ that has been pumped into the cells can diffuse back out.",
"   </p>",
"   <p>",
"    These reabsorptive processes are dependent upon the maintenance of normal membrane polarity in which the transporters, channels, and Na+-K+-ATPase pump are correctly located. Both experimental animals and humans often have delayed recovery of tubular Na+ reabsorption after a period of renal ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Studies in animals suggest that this defect may result from the loss of membrane polarity, as an ischemia-induced increase in the permeability of the tight junction allows the lateral movement of Na+-K+-ATPase pumps from the basolateral to the luminal membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Loss of Na+-K+-ATPase pumps from the proximal tubule basolateral membrane has also been demonstrated in renal transplant recipients in whom there is a delay in graft reperfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Mechanisms of chloride reabsorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;After Na+, Cl- is the most prevalent ion in the filtrate. Both active and passive processes contribute to proximal Cl- reabsorption, each of which is indirectly linked to active Na+ transport [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/38\">",
"     38",
"    </a>",
"    ]. Active Cl- reabsorption appears to occur via an anion exchanger in the luminal membrane, in which luminal Cl- is exchanged at least in part for cellular formate. Although the formate concentration is only about 0.25 to 0.5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in the filtrate, this anion is able to promote Cl- reabsorption because it is recycled across the luminal membrane (",
"    <a class=\"graphic graphic_figure graphicRef72332 \" href=\"UTD.htm?23/54/24429\">",
"     figure 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. Filtered formate initially combines with H+ secreted by the Na+-H+ antiporter to form formic acid (HF). The latter is uncharged and able to freely diffuse across the luminal membrane. The cell, however, has a lower H+ concentration than the lumen, due to the secretion of H+. As a result, the reaction,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;HF &nbsp; &lt;&mdash;&gt; &nbsp; &nbsp;H+ &nbsp;+ &nbsp;Formate-",
"   </p>",
"   <p>",
"    within the cell is driven to the right. The H+ is then secreted again, while the formate returns to the lumen via a formate-chloride exchanger on the brush border membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/41\">",
"     41",
"    </a>",
"    ]. Formic acid is reformed in the lumen and the process can be repeated. The energy for these ion exchangers is again provided indirectly by the Na+-K+-ATPase pump. By maintaining a low cell Na+ concentration, this pump allows the continued Na+-H+ exchange that is essential for formate recycling. If, on the other hand, the proximal Na+-H+ exchanger is inhibited, there is a parallel inhibition of almost all of active transcellular chloride transport [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The quantitative role of formate in Cl- reabsorption is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/44\">",
"     44",
"    </a>",
"    ]. As a result, it has been speculated that other anion exchangers, such as chloride-hydroxyl or chloride-oxalate exchangers, also play a contributory role [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/40,42,44-46\">",
"     40,42,44-46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Regardless of the mechanism, the reabsorbed Cl- is returned to the systemic circulation across the basolateral membrane. Both a selective Cl- channel and a KCl cotransporter appear to contribute to Cl- exit [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/40,47\">",
"     40,47",
"    </a>",
"    ], but other transporters also may play a role [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/48\">",
"     48",
"    </a>",
"    ]. The energy for these transport processes is respectively provided by the cell interior negative potential and by the high cell K+ concentration in relation to that in the interstitium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Passive mechanisms of proximal transport",
"    </span>",
"    &nbsp;&mdash;&nbsp;Passive mechanisms appear to account for about one-third of proximal fluid reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/11,12,14\">",
"     11,12,14",
"    </a>",
"    ]. The mechanism by which this occurs is as follows. The early proximal convoluted tubule reabsorbs most of the filtered glucose, amino acids, and HCO3-, but a lesser amount of Cl- (",
"    <a class=\"graphic graphic_figure graphicRef80438 \" href=\"UTD.htm?9/31/9726\">",
"     figure 1",
"    </a>",
"    ). Water is then reabsorbed down an osmotic gradient [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The net effect is that the tubular fluid has an osmolality similar to that of the plasma, a higher chloride concentration, and relatively little glucose, bicarbonate, or amino acids. In contrast, the intercellular spaces in the later segments of the proximal tubule have solute concentrations similar to that of the plasma, since they are in equilibrium with fluid in the peritubular capillary (",
"    <a class=\"graphic graphic_figure graphicRef62640 \" href=\"UTD.htm?24/53/25437\">",
"     figure 7",
"    </a>",
"    ). If the tight junction were equally permeable to all solutes, there would be no net fluid movement, since the effective osmolalities of the two solutions would be similar. However, the permeability to Cl- exceeds that to the other solutes, particularly HCO3- [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/14,49\">",
"     14,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this setting, passive fluid reabsorption can occur across the tight junction into the intercellular space by two mechanisms&dagger;:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chloride can traverse the tight junction down its concentration gradient, with sodium and water then following down respective electrical and osmotic gradients. (Bicarbonate, glucose, and amino acids do not move in the opposite direction to the same degree since the tight junction is much less permeable to these solutes.) The presence of primary Cl- transport has been demonstrated by the finding of a transepithelial potential difference that is lumen positive (due to the reabsorption of the anion Cl-) in the late proximal tubule [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/12\">",
"       12",
"      </a>",
"      ]. The potential difference would be lumen negative if Na+ transport were the primary event.",
"     </li>",
"     <li>",
"      Water can move across the tight junction down an osmotic gradient, with sodium chloride following both by solvent drag and by diffusion since the loss of water raises the solute concentrations in the lumen [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/4\">",
"       4",
"      </a>",
"      ]. This movement of water occurs because the tight junction is preferentially permeable to Cl- [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/49\">",
"       49",
"      </a>",
"      ]; as a result, Cl- is a relatively",
"      <strong>",
"       ineffective",
"      </strong>",
"      osmole (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30771?source=see_link&amp;anchor=H4#H4\">",
"       \"Chapter 1B: Units of solute measurement\", section on 'Osmotic pressure and osmolality'",
"      </a>",
"      ) Thus, the effective osmolality in the intercellular space exceeds that in the lumen (thereby promoting water reabsorption), even though the total osmolality is the same in both compartments [",
"      <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;&dagger;Passive fluid reabsorption appears to occur only in the outer cortical and midcortical nephrons. In contrast, active Na+ transport appears to account for almost all NaCl reabsorption in the juxtamedullary proximal tubules, which are not preferentially permeable to chloride [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/12,49\">",
"     12,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is likely that HCO3- is the most important of the solutes that promote passive transport, since it is present in the highest concentration (24",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    versus only 5",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    [90",
"    <span class=\"nowrap\">",
"     mg/dL]",
"    </span>",
"    for glucose). A clinical example of the effect of HCO3- is seen in the response to the administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    . This proximally acting diuretic is a carbonic anhydrase inhibitor that diminishes the reabsorption of bicarbonate. It also produces a substantial reduction in proximal NaCl reabsorption, even though it has no known direct action on Cl- transport [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/50\">",
"     50",
"    </a>",
"    ]. This chloruresis presumably reflects diminished passive reabsorption, resulting from the decrease in HCO3- transport.",
"   </p>",
"   <p>",
"    A similar reduction in proximal NaCl reabsorption occurs in metabolic acidosis, a disorder in which the plasma HCO3- concentration is decreased (see Chap. 19) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/51\">",
"     51",
"    </a>",
"    ]. In this setting, less HCO3- is filtered (because of the low plasma level) and therefore less is available for proximal reabsorption.",
"   </p>",
"   <p>",
"    In summary, other than the Na+-K+-ATPase pump, the Na+-H+ antiporter is the main determinant of proximal Na+ and water reabsorption. It has three major effects on proximal transport: (1) it directly promotes HCO3- reabsorption, particularly in the early proximal tubule; (2) the preferential reabsorption of HCO3- and water creates the gradient for the passive reabsorption of Cl-; and (3) it promotes active Cl- reabsorption by operating in parallel with the Cl-",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    formate and other",
"    <span class=\"nowrap\">",
"     Cl-/anion",
"    </span>",
"    exchangers. It is not surprising, therefore, that activity of the Na+-H+ exchanger varies appropriately with salt intake: increasing on a low salt diet (when enhanced proximal reabsorption will tend to prevent volume depletion) and decreasing on a high salt diet [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neurohumoral influences",
"    </span>",
"    &nbsp;&mdash;&nbsp;These diet-induced changes in proximal Na+-H+ exchange and NaCl and water reabsorption are mediated at least in part by angiotensin II and norepinephrine&dagger; [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/52-55\">",
"     52-55",
"    </a>",
"    ]. The secretion of these hormones varies inversely with the effective circulating volume. Thus, volume depletion increases angiotensin II and norepinephrine release, leading to enhanced proximal transport and an appropriate reduction in urinary sodium excretion.",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;&dagger;Angiotensin II and norepinephrine also promote proximal transport by their vasoconstrictive effects which, by increasing the filtration fraction, increases uptake of the reabsorbate by the peritubular capillary (see below).",
"   </p>",
"   <p>",
"    Although angiotensin II increases the activity of the Na+-H+ exchanger and enhances HCO3- reabsorption in the early (S1 segment) proximal tubule, it does not induce an important change in net proximal HCO3- transport. This finding is related to the flow-dependence of HCO3- but not Cl- reabsorption in the later S2 segment. Thus, the increase in HCO3- reabsorption in the initial proximal tubule leads to a reduction in HCO3- delivery to and therefore a fall in HCO3- reabsorption in the later proximal segments [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/53,56\">",
"     53,56",
"    </a>",
"    ]. The net effect is no net change in delivery of HCO3- out of the proximal tubule. There is, however, decreased distal Cl- delivery, since there is no adaptive decrease in late proximal Cl- transport [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, angiotensin II has an overall stimulatory effect on proximal NaCl and H2O reabsorption, but not usually on net acidification. Angiotensin II may be responsible for as much as 40 to 50 percent of NaCl and H2O transport in the S1 segment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/57\">",
"     57",
"    </a>",
"    ]. There is a much smaller effect in the more distal proximal tubule where there are fewer angiotensin II receptors.",
"   </p>",
"   <p>",
"    Dopamine is another hormone that regulates proximal transport, acting to diminish Na+ reabsorption. This effect is associated with partial inhibition of both of the major steps involved in transtubular Na+ transport: (1) decreased activity of the Na+-H+ exchanger, thereby reducing the entry of luminal Na+ into the cell [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/55,58\">",
"     55,58",
"    </a>",
"    ]; and (2) reduced activity of the basolateral Na+-K+-ATPase pump, perhaps due to phosphorylation of the pump by a dopamine-dependent phosphoprotein [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These actions of dopamine may be physiologically important, since dopamine production is enhanced by volume expansion. Furthermore, blocking the effect of dopamine with a receptor antagonist attenuates the natriuretic response to volume expansion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Capillary uptake",
"    </span>",
"    &nbsp;&mdash;&nbsp;The movement of the reabsorbate from the intercellular space into the peritubular capillary (derived from the efferent arteriole) is governed by Starling's forces (",
"    <a class=\"graphic graphic_figure graphicRef57332 \" href=\"UTD.htm?28/25/29085\">",
"     figure 8",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Capillary uptake &nbsp; &nbsp; = &nbsp; LpS",
"    <span class=\"nowrap\">",
"     (&Delta;",
"    </span>",
"    oncotic pressure &nbsp;- &nbsp;",
"    <span class=\"nowrap\">",
"     &Delta;",
"    </span>",
"    hydraulic pressure)",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;= &nbsp; LpS ( s [&pi;ptc &nbsp;- &nbsp;&pi;if] &nbsp;- &nbsp;[Pptc &nbsp; - &nbsp;Pif] )",
"   </p>",
"   <p>",
"    where Lp is the unit porosity of the capillary wall, S is the surface area available for absorption, s is the reflection coefficient of proteins across the capillary wall (ranging from 0 if freely permeable to 1 if completely impermeable), &pi;ptc and &pi;if are the oncotic pressures in the peritubular capillary and interstitium, and Pptc and Pif are the hydraulic pressures in the capillary and interstitium.",
"   </p>",
"   <p>",
"    The approximate normal values for the hydraulic and oncotic pressures in the peritubular capillary are depicted in Figure 1 (",
"    <a class=\"graphic graphic_figure graphicRef57332 \" href=\"UTD.htm?28/25/29085\">",
"     figure 8",
"    </a>",
"    ). The mean hydraulic pressure is much less than arterial pressure due to the resistances at the glomerular arterioles. In contrast, the oncotic pressure is higher than that in the systemic circulation because of the removal of protein-free filtrate in the glomerulus. The net effect is a relatively large gradient (&pi;ptc &nbsp; - &nbsp; Pptc equals 13 mmHg) within the capillary that favors fluid uptake from the intercellular space &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/62\">",
"     62",
"    </a>",
"    ]. This gradient will be somewhat dissipated along the length of the proximal tubule, since uptake of the reabsorbate will lower the &pi;ptc by dilution. In comparison, the hydraulic and oncotic pressures in the interstitial fluid are of lesser magnitude (less than 5 mmHg) and generally make a smaller contribution to net fluid movement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One way that net fluid reabsorption can be regulated is by alterations in these capillary hemodynamic forces, which are influenced by glomerular arteriolar tone. As an example, the degree to which the systemic blood pressure is transmitted to the peritubular capillary is dependent upon glomerular arteriolar resistance. Arteriolar constriction increases the pressure drop across the glomerulus, thereby reducing peritubular capillary hydraulic pressure; arteriolar dilation, in comparison, allows the peritubular capillary pressure to rise toward that in the systemic circulation.",
"   </p>",
"   <p>",
"    The capillary oncotic pressure, on the other hand, is determined by two factors: the baseline plasma protein concentration and the fraction of the renal plasma flow (RPF) that is filtered across the glomerulus (called the filtration fraction,",
"    <span class=\"nowrap\">",
"     GFR/RPF).",
"    </span>",
"    If relatively more fluid is filtered, i.e., if the filtration fraction is increased, there will be a greater than usual elevation in the protein concentration in the fluid leaving the glomerulus and entering the peritubular capillary. Changes in the filtration fraction are primarily induced by changes in resistance at the efferent arteriole. Efferent arteriolar constriction will tend to raise the GFR (by increasing glomerular hydraulic pressure) and lower the RPF (because of the elevation in renal vascular resistance), thereby increasing the filtration fraction and the peritubular capillary oncotic pressure.",
"   </p>",
"   <p>",
"    Thus, alterations in peritubular capillary hemodynamics induced by efferent arteriolar constriction &mdash; increased oncotic pressure, reduced hydraulic pressure &mdash; promote capillary uptake and net proximal reabsorption. This becomes clinically important because both angiotensin II and norepinephrine, released in response to effective circulating volume depletion, increase the resistance at the efferent and, to a lesser degree, the afferent arteriole, thereby raising the filtration fraction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/63\">",
"     63",
"    </a>",
"    ]. In congestive heart failure, for example, angiotensin II and norepinephrine levels, the filtration fraction, and proximal reabsorption are all frequently elevated, thereby contributing to the low rate of Na+ and water excretion that is commonly seen (see Chap. 16) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/64\">",
"     64",
"    </a>",
"    ]. (As described above, angiotensin II and norepinephrine also promote proximal Na+ reabsorption via stimulation of Na+-H+ exchange [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/53,55,57\">",
"     53,55,57",
"    </a>",
"    ].)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Backflux across the tight junction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism by which changes in peritubular capillary hemodynamics influence proximal reabsorption is incompletely understood [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/4\">",
"     4",
"    </a>",
"    ]. It has been suggested that fluid transported into the intercellular space can either move into the peritubular capillary or leak back into the lumen across the tight junction. This choice is influenced in part by the balance of Starling's forces across the capillary wall. In volume expansion, for example, enhanced movement of raffinose or sucrose from the peritubular capillary into the tubular lumen has been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/65\">",
"     65",
"    </a>",
"    ]. Since these sugars do not enter cells, this movement must reflect increased permeability of the tight junction, and suggests that the associated reduction in proximal reabsorption may be mediated by increased backflux from the intercellular space into the lumen.",
"   </p>",
"   <p>",
"    Changes in capillary hemodynamics may play an important role in this response. Both angiotensin II and norepinephrine release are diminished by hypervolemia; the ensuing efferent arteriolar dilation could lower the filtration fraction and impair capillary uptake, thereby promoting backleak across the tight junction.",
"   </p>",
"   <p>",
"    There is, however, a major problem with this passive backflux theory. Microperfusion studies have demonstrated that lowering the oncotic pressure in the peritubular capillary reduces the reabsorption of NaCl, but not that of glucose or HCO3- [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/66\">",
"     66",
"    </a>",
"    ]. Although this could be explained by the known higher permeability of the tight junction to Cl- [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/14,49\">",
"     14,49",
"    </a>",
"    ], it is the active, not passive reabsorption of NaCl that is impaired [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Glomerulotubular balance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficiency with which proximal transport is regulated can be appreciated from the phenomenon of glomerulotubular balance. The urinary excretion of Na+ and water is equal to the difference between the amount filtered across the glomerulus and the amount reabsorbed by the tubules. To maintain the extracellular fluid volume, it is important that tubular reabsorption varies with the spontaneous changes (some of which are diet-induced) that can occur in the GFR.",
"   </p>",
"   <p>",
"    As an example, a normal adult male filters approximately 180",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    (125",
"    <span class=\"nowrap\">",
"     mL/min);",
"    </span>",
"    the urine output, however, is usually only 1 to 2 L as over 98 percent of the filtrate is reabsorbed. If there were a slight elevation in GFR to 183",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    but no change in tubular reabsorption, the result would be a 3-liter increase in urine output and a serious reduction in the extracellular fluid volume. Fortunately, this does not occur since, over a wide range of spontaneous and experimental variations in the GFR, there is a proportional change in tubular reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/68-70\">",
"     68-70",
"    </a>",
"    ]. Thus, a 1.5 percent increase in the GFR (from 180 to 183",
"    <span class=\"nowrap\">",
"     L/day)",
"    </span>",
"    is associated with a similar increment in tubular reabsorption, resulting in only a small elevation in the urine output.",
"   </p>",
"   <p>",
"    This response, in which the absolute level of tubular reabsorption is directly related to the filtration rate, is called glomerulotubular balance. Notice that, at all levels of GFR in Figure 2 (",
"    <a class=\"graphic graphic_figure graphicRef77558 \" href=\"UTD.htm?36/14/37100\">",
"     figure 9",
"    </a>",
"    ), approximately 60 percent of the filtrate is reabsorbed in the proximal tubule. Similarly, the more distal nephron segments reabsorb a constant fraction of the load delivered to them from the proximal tubule [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. This is another way to define glomerulotubular balance: that the fractional tubular reabsorption remains roughly constant despite changes in the GFR.",
"   </p>",
"   <p>",
"    The mechanism by which glomerulotubular balance is mediated in the proximal tubule is incompletely understood, but both peritubular and luminal factors are thought to contribute [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/68,71,72\">",
"     68,71,72",
"    </a>",
"    ]. If, for example, the GFR increases while RPF remains constant, the protein concentration in the plasma leaving the glomerulus will rise due to the loss of more protein-free filtrate. The ensuing elevation in the oncotic pressure in the peritubular capillary can then enhance net proximal reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/71,72\">",
"     71,72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is likely that &nbsp;the presence of factors in the filtrate that enhance Na+ and H2O reabsorption also play a major role in glomerulotubular balance in the proximal tubule [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/68\">",
"     68",
"    </a>",
"    ]. As described in Chapter 3A, bicarbonate, glucose, and amino acids augment Na+ reabsorption both by cotransporting carriers in the luminal membrane and by the subsequent creation of chloride and osmotic gradients for passive reabsorption (",
"    <a class=\"graphic graphic_figure graphicRef62640 \" href=\"UTD.htm?24/53/25437\">",
"     figure 7",
"    </a>",
"    ). An elevation in GFR will augment the filtered load of these (and other) solutes, and their subsequent reabsorption can contribute to glomerulotubular balance for Na+ and H2O [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Glomerulotubular balance in the proximal tubule, loop of Henle, and distal tubule is one of three intrarenal mechanisms that act to prevent fluid delivery from exceeding the limited total reabsorptive capacity of the collecting tubules [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/70\">",
"     70",
"    </a>",
"    ]. The others are",
"    <strong>",
"     autoregulation",
"    </strong>",
"    , which keeps the GFR relatively constant despite variations in renal arterial pressure, and",
"    <strong>",
"     tubuloglomerular feedback",
"    </strong>",
"    , which lowers the GFR if the load to the macula densa segment of the early distal tubule is increased. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10985?source=see_link\">",
"     \"Chapter 2D: Regulation of GFR and renal plasma flow\"",
"    </a>",
"    .) Thus, one view of nephron function is that the proximal tubule and loop of Henle are responsible for the reabsorption of the bulk of the filtrate, with the distal nephron (particularly the collecting tubules) making small variations in electrolyte and water excretion in accordance with changes in intake [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/73\">",
"     73",
"    </a>",
"    ]. This process operates most efficiently if the distal delivery of filtrate is kept at a nearly constant level.",
"   </p>",
"   <p>",
"    The relationship between glomerular filtration and tubular reabsorption is not fixed, and may be reset at a different level when there are changes in the effective circulating volume. The fraction of the filtered Na+ and water reabsorbed in the proximal tubule tends to be increased by volume depletion and decreased by volume expansion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. These changes are appropriate, however, since the maintenance of constant fractional Na+ reabsorption is not desirable in these conditions. Enhanced reabsorption leading to Na+ and water retention is a proper response to volume depletion. As mentioned previously, these changes are mediated at least in part by angiotensin II and norepinephrine (either circulating or released from the renal sympathetic nerves) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/53,55-57\">",
"     53,55-57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proximal tubule reabsorbs isosmotically about 55 to 60 percent of the filtrate. This process occurs in three steps: entry into the cell across the luminal membrane, movement across the basolateral membrane into the intercellular space, and uptake by the peritubular capillary. Despite the large amount of reabsorption that occurs, the only major active (energy-requiring) step is mediated by the Na+-K+-ATPase pump in the basolateral membrane. In addition to directly promoting Na+ reabsorption, this pump maintains the low cell Na+ concentration that allows passive Na+ entry into the cell.",
"   </p>",
"   <p>",
"    The reabsorption of many other solutes (such as glucose, phosphate, amino acids, and bicarbonate) occurs by carrier-mediated coupled transport with Na+ across the luminal membrane. Furthermore, the preferential reabsorption of these solutes with Na+ in the early proximal tubule creates osmotic and concentration gradients that permit about one-third of total proximal Na+ and H2O reabsorption to occur passively through the tight junction (",
"    <a class=\"graphic graphic_figure graphicRef62640 \" href=\"UTD.htm?24/53/25437\">",
"     figure 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Uptake by the peritubular capillary of fluid transported into the intercellular space is regulated by Starling's forces. Depending upon the magnitude of these forces, which can be influenced by vasoactive hormones, the reabsorbate either enters the capillary and is returned to the systemic circulation or leaks back into the lumen across the tight junction. Modulations in net proximal tubular reabsorption appear to be influenced by luminal, peritubular capillary, and neurohumoral factors.",
"   </p>",
"   <p>",
"    The data upon which the above conclusions are based were primarily obtained from studies in experimental animals. Human studies are, of course, more limited. However, the importance of luminal membrane cotransporters in humans was suggested by findings in an infant who was born without the proximal tubular brush border and presumably without the carrier proteins that it normally contains. This child had",
"    <strong>",
"     no tubular reabsorption",
"    </strong>",
"    of glucose, amino acids, or phosphate, as evidenced by a rate of excretion for these compounds that was essentially equal to the filtered load (determined from the GFR times the plasma concentration) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/2/24617/abstract/76\">",
"     76",
"    </a>",
"    ]. The plasma bicarbonate concentration was 11",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (normal equals about 24",
"    <span class=\"nowrap\">",
"     meq/L);",
"    </span>",
"    assuming that proximal bicarbonate reabsorption by the Na+-H+ antiporter was also negligible, this value of 11",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    presumably reflects the bicarbonate reabsorptive capacity of the more distal segments. This distal contribution probably explains why patients with type 2 (or proximal) renal tubular acidosis, who have an impairment in proximal bicarbonate reabsorption, usually are able to maintain their plasma bicarbonate concentration at or above 12",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"   </p>",
"   <p>",
"    This text is continued elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36905?source=see_link\">",
"     \"Chapter 3B: Primacy of sodium transport in proximal function\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/1\">",
"      Maddox DA, Gennari FJ. The early proximal tubule: a high-capacity delivery-responsive reabsorptive site. Am J Physiol 1987; 252:F573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/2\">",
"      Woodhall PB, Tisher CC, Simonton CA, Robinson RR. Relationship between para-aminohippurate secretion and cellular morphology in rabbit proximal tubules. J Clin Invest 1978; 61:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/3\">",
"      Helbert MJ, Dauwe SE, Van der Biest I, et al. Immunodissection of the human proximal nephron: flow sorting of S1S2S3, S1S2 and S3 proximal tubular cells. Kidney Int 1997; 52:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/4\">",
"      Rector FC Jr. Sodium, bicarbonate, and chloride absorption by the proximal tubule. Am J Physiol 1983; 244:F461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/5\">",
"      Kinne RK. Selectivity and direction: plasma membranes in renal transport. Am J Physiol 1991; 260:F153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/6\">",
"      Gumbiner B. Structure, biochemistry, and assembly of epithelial tight junctions. Am J Physiol 1987; 253:C749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/7\">",
"      Nielsen S, Kwon TH, Christensen BM, et al. Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol 1999; 10:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/8\">",
"      Lee MD, King LS, Agre P. The aquaporin family of water channel proteins in clinical medicine. Medicine (Baltimore) 1997; 76:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/9\">",
"      Saboli�� I, Valenti G, Verbavatz JM, et al. Localization of the CHIP28 water channel in rat kidney. Am J Physiol 1992; 263:C1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/10\">",
"      Schnermann J, Chou CL, Ma T, et al. Defective proximal tubular fluid reabsorption in transgenic aquaporin-1 null mice. Proc Natl Acad Sci U S A 1998; 95:9660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/11\">",
"      Neumann KH, Rector FC Jr. Mechanism of NaCl and water reabsorption in the proximal convoluted tubule of rat kidney. J Clin Invest 1976; 58:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/12\">",
"      Jacobson HR. Characteristics of volume reabsorption in rabbit superficial and juxtamedullary proximal convoluted tubules. J Clin Invest 1979; 63:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/13\">",
"      Katz AI. Distribution and function of classes of ATPases along the nephron. Kidney Int 1986; 29:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/14\">",
"      Schafer JA. Robert F. Pitts Memorial Lecture. Mechanisms coupling the absorption of solutes and water in the proximal nephron. Kidney Int 1984; 25:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/15\">",
"      Green R, Giebisch G. Osmotic forces driving water reabsorption in the proximal tubule of the rat kidney. Am J Physiol 1989; 257:F669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/16\">",
"      Gullans SR, Avison MJ, Ogino T, et al. NMR measurements of intracellular sodium in the rabbit proximal tubule. Am J Physiol 1985; 249:F160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/17\">",
"      Kone BC, Brady HR, Gullans SR. Coordinated regulation of intracellular K+ in the proximal tubule: Ba2+ blockade down-regulates the Na+,K+-ATPase and up-regulates two K+ permeability pathways. Proc Natl Acad Sci U S A 1989; 86:6431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/18\">",
"      Hurst AM, Beck JS, Laprade R, Lapointe JY. Na+ pump inhibition downregulates an ATP-sensitive K+ channel in rabbit proximal convoluted tubule. Am J Physiol 1993; 264:F760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/19\">",
"      Sacktor B. Sodium-coupled hexose transport. Kidney Int 1989; 36:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/20\">",
"      Turner RJ, Moran A. Heterogeneity of sodium-dependent D-glucose transport sites along the proximal tubule: evidence from vesicle studies. Am J Physiol 1982; 242:F406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/21\">",
"      Zelikovic I, Chesney RW. Sodium-coupled amino acid transport in renal tubule. Kidney Int 1989; 36:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/22\">",
"      Murer H, L&ouml;tscher M, Kaissling B, et al. Renal brush border membrane Na/Pi-cotransport: molecular aspects in PTH-dependent and dietary regulation. Kidney Int 1996; 49:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/23\">",
"      Malnic G. Robert F. Pitts memorial lecture. H+ secretion in renal cortical tubules: kinetic aspects. Kidney Int 1987; 32:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/24\">",
"      Alpern RJ, Moe OW, Preisig PA. Chronic regulation of the proximal tubular Na/H antiporter: from HCO3 to SRC. Kidney Int 1995; 48:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/25\">",
"      Hoshi T. Robert F. Pitts memorial lecture. Electrophysiology of Triturus nephron: cable properties and electrogenic transport systems. Kidney Int 1990; 37:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/26\">",
"      Williams KA. Three-dimensional structure of the ion-coupled transport protein NhaA. Nature 2000; 403:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/27\">",
"      Burg M, Patlak C, Green N, Villey D. Organic solutes in fluid absorption by renal proximal convoluted tubules. Am J Physiol 1976; 231:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/28\">",
"      Barfuss DW, Schafer JA. Rate of formation and composition of absorbate from proximal nephron segments. Am J Physiol 1984; 247:F117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/29\">",
"      Avison MJ, Gullans SR, Ogino T, et al. Measurement of Na+-K+ coupling ratio of Na+-K+-ATPase in rabbit proximal tubules. Am J Physiol 1987; 253:C126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/30\">",
"      Soleimani M, Grassi SM, Aronson PS. Stoichiometry of Na+-HCO-3 cotransport in basolateral membrane vesicles isolated from rabbit renal cortex. J Clin Invest 1987; 79:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/31\">",
"      Beck JS, Breton S, Mairb&auml;url H, et al. Relationship between sodium transport and intracellular ATP in isolated perfused rabbit proximal convoluted tubule. Am J Physiol 1991; 261:F634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/32\">",
"      Hanley MJ. Isolated nephron segments in a rabbit model of ischemic acute renal failure. Am J Physiol 1980; 239:F17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/33\">",
"      Myers BD, Miller DC, Mehigan JT, et al. Nature of the renal injury following total renal ischemia in man. J Clin Invest 1984; 73:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/34\">",
"      Molitoris BA, Falk SA, Dahl RH. Ischemia-induced loss of epithelial polarity. Role of the tight junction. J Clin Invest 1989; 84:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/35\">",
"      Molitoris BA. Ischemia-induced loss of epithelial polarity: potential role of the actin cytoskeleton. Am J Physiol 1991; 260:F769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/36\">",
"      Sutton TA, Molitoris BA. Mechanisms of cellular injury in ischemic acute renal failure. Semin Nephrol 1998; 18:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/37\">",
"      Kwon O, Corrigan G, Myers BD, et al. Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft. Kidney Int 1999; 55:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/38\">",
"      Berry CA, Rector FC Jr. Electroneutral NaCl absorption in the proximal tubule: mechanisms of apical Na-coupled transport. Kidney Int 1989; 36:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/39\">",
"      Schild L, Giebisch G, Karniski LP, Aronson PS. Effect of formate on volume reabsorption in the rabbit proximal tubule. J Clin Invest 1987; 79:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/40\">",
"      Wang T, Giebisch G, Aronson PS. Effects of formate and oxalate on volume absorption in rat proximal tubule. Am J Physiol 1992; 263:F37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/41\">",
"      Knauf F, Yang CL, Thomson RB, et al. Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells. Proc Natl Acad Sci U S A 2001; 98:9425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/42\">",
"      Wang T, Egbert AL Jr, Abbiati T, et al. Mechanisms of stimulation of proximal tubule chloride transport by formate and oxalate. Am J Physiol 1996; 271:F446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/43\">",
"      Preisig PA, Rector FC Jr. Role of Na+-H+ antiport in rat proximal tubule NaCl absorption. Am J Physiol 1988; 255:F461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/44\">",
"      Preisig PA, Alpern RJ. Contributions of cellular leak pathways to net NaHCO3 and NaCl absorption. J Clin Invest 1989; 83:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/45\">",
"      Kurtz I, Nagami G, Yanagawa N, et al. Mechanism of apical and basolateral Na(+)-independent Cl-/base exchange in the rabbit superficial proximal straight tubule. J Clin Invest 1994; 94:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/46\">",
"      Aronson PS. Ion exchangers mediating NaCl transport in the proximal tubule. Wien Klin Wochenschr 1997; 109:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/47\">",
"      Sasaki S, Ishibashi K, Yoshiyama N, Shiigai T. KCl co-transport across the basolateral membrane of rabbit renal proximal straight tubules. J Clin Invest 1988; 81:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/48\">",
"      Ullrich KJ, Capasso G, Rumrich G, et al. Coupling between proximal tubular transport processes. Studies with ouabain, SITS and HCO3-free solutions. Pflugers Arch 1977; 368:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/49\">",
"      Green R, Giebisch G. Reflection coefficients and water permeability in rat proximal tubule. Am J Physiol 1989; 257:F658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/50\">",
"      Mathisen O, Monclair T, Holdaas H, Kiil F. Bicarbonate as mediator of proximal tubular NaCl reabsorption and glomerulotubular balance. Scand J Clin Lab Invest 1978; 38:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/51\">",
"      Cogan MG, Rector FC Jr. Proximal reabsorption during metabolic acidosis in the rat. Am J Physiol 1982; 242:F499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/52\">",
"      Moe OW, Tejedor A, Levi M, et al. Dietary NaCl modulates Na(+)-H+ antiporter activity in renal cortical apical membrane vesicles. Am J Physiol 1991; 260:F130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/53\">",
"      Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990; 15:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/54\">",
"      Liu FY, Cogan MG. Angiotensin II stimulates early proximal bicarbonate absorption in the rat by decreasing cyclic adenosine monophosphate. J Clin Invest 1989; 84:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/55\">",
"      Gesek FA, Schoolwerth AC. Hormonal interactions with the proximal Na(+)-H+ exchanger. Am J Physiol 1990; 258:F514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/56\">",
"      Liu FY, Cogan MG. Role of angiotensin II in glomerulotubular balance. Am J Physiol 1990; 259:F72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/57\">",
"      Cogan MG, Xie MH, Liu FY, et al. Effects of DuP 753 on proximal nephron and renal transport. Am J Hypertens 1991; 4:315S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/58\">",
"      Felder CC, Campbell T, Albrecht F, Jose PA. Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 1990; 259:F297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/59\">",
"      Aperia A, Fryckstedt J, Svensson L, et al. Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells. Proc Natl Acad Sci U S A 1991; 88:2798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/60\">",
"      Bertorello A, Aperia A. Regulation of Na+-K+-ATPase activity in kidney proximal tubules: involvement of GTP binding proteins. Am J Physiol 1989; 256:F57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/61\">",
"      Hansell P, Fasching A. The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int 1991; 39:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/62\">",
"      Ichikawa I, Brenner BM. Mechanism of inhibition of proximal tubule fluid reabsorption after exposure of the rat kidney to the physical effects of expansion of extracellular fluid volume. J Clin Invest 1979; 64:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/63\">",
"      Tucker BJ, Mundy CA, Blantz RC. Adrenergic and angiotensin II influences on renal vascular tone in chronic sodium depletion. Am J Physiol 1987; 252:F811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/64\">",
"      Dzau VJ. Renal and circulatory mechanisms in congestive heart failure. Kidney Int 1987; 31:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/65\">",
"      Boulpaep EL. Permeability changes of the proximal tubule of Necturus during saline loading. Am J Physiol 1971; 222:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/66\">",
"      Berry CA, Cogan MG. Influence of peritubular protein on solute absorption in the rabbit proximal tubule. A specific effect on NaCl transport. J Clin Invest 1982; 68:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/67\">",
"      Baum M, Berry CA. Peritubular protein modulates neutral active NaCl absorption in rabbit proximal convoluted tubule. Am J Physiol 1985; 248:F790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/68\">",
"      H&auml;berle DA, von Baeyer H. Characteristics of glomerulotubular balance. Am J Physiol 1983; 244:F355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/69\">",
"      Wright FS. Flow-dependent transport processes: filtration, absorption, secretion. Am J Physiol 1982; 243:F1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/70\">",
"      Kunau RT Jr, Webb HL, Borman SC. Characteristics of sodium reabsorption in the loop of Henle and distal tubule. Am J Physiol 1974; 227:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/71\">",
"      Brenner BM, Troy JL. Postglomerular vascular protein concentration: evidence for a causal role in governing fluid reabsorption and glomerulotublar balance by the renal proximal tubule. J Clin Invest 1971; 50:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/72\">",
"      Ichikawa I, Hoyer JR, Seiler MW, Brenner BM. Mechanism of glomerulotubular balance in the setting of heterogeneous glomerular injury. Preservation of a close functional linkage between individual nephrons and surrounding microvasculature. J Clin Invest 1982; 69:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/73\">",
"      Moore LC. Interaction of tubuloglomerular feedback and proximal nephron reabsorption in autoregulation. Kidney Int 1982; 22(suppl 12):S-173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/74\">",
"      DIRKS JH, CIRKSENA WJ, BERLINER RW. THE EFFECTS OF SALINE INFUSION ON SODIUM REABSORPTION BY THE PROXIMAL TUBULE OF THE DOG. J Clin Invest 1965; 44:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/75\">",
"      Stein JH, Osgood RW, Boonjarern S, et al. Segmental sodium reabsorption in rats with mild and severe volume depletion. Am J Physiol 1974; 227:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/2/24617/abstract/76\">",
"      Manz F, Waldherr R, Fritz HP, et al. Idiopathic de Toni-Debr&eacute;-Fanconi syndrome with absence of proximal tubular brush border. Clin Nephrol 1984; 22:149.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7280 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-4E972C53F8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24617=[""].join("\n");
var outline_f24_2_24617=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CELL MODEL FOR PROXIMAL TRANSPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cell entry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Movement into the intercellular space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Mechanisms of chloride reabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Passive mechanisms of proximal transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neurohumoral influences",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Capillary uptake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Backflux across the tight junction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Glomerulotubular balance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7280\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7280|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/31/9726\" title=\"figure 1\">",
"      Proximal solute gradients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/29/23006\" title=\"figure 2\">",
"      Proximal tubule segments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/36/30286\" title=\"figure 3\">",
"      Proximal tubule transport I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/6/19566\" title=\"figure 4\">",
"      Proximal tubule transport II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/26/36269\" title=\"figure 5\">",
"      Sodium glucose cotransport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/54/24429\" title=\"figure 6\">",
"      Formate and Cl transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/53/25437\" title=\"figure 7\">",
"      Passive proximal Cl transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/25/29085\" title=\"figure 8\">",
"      Peritubular capillary uptake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/14/37100\" title=\"figure 9\">",
"      Glomerulotubular balance",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12762?source=related_link\">",
"      Chapter 11A: Renal hydrogen excretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30771?source=related_link\">",
"      Chapter 1B: Units of solute measurement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10985?source=related_link\">",
"      Chapter 2D: Regulation of GFR and renal plasma flow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36905?source=related_link\">",
"      Chapter 3B: Primacy of sodium transport in proximal function",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_2_24618="Atopic dermatitis popliteal";
var content_f24_2_24618=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68215%7EPC%2F65407%7EPC%2F52163%7EDERM%2F55424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68215%7EPC%2F65407%7EPC%2F52163%7EDERM%2F55424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atopic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperpigmented, slightly scaly patches and lichenified plaques are present in the popliteal fossae of this patient with atopic dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Atopic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Severe atopic dermatitis in a 12-year-old girl showing in the typical location of the popliteal fossae. Note the oozing of serous fluid from the most involved areas, plus the papular component and erythema.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott Walsh, MD, FRPCP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flexural atopic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 218px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical appearance of atopic dermatitis in flexural areas of the legs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James C Shaw, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atopic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 325px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous erythematous papules are present on the hands of this patient with atopic dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24618=[""].join("\n");
var outline_f24_2_24618=null;
var title_f24_2_24619="Causes of inguinal swelling in children";
var content_f24_2_24619=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of inguinal swelling in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Male or Female",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inguinal hernia (direct or indirect)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inguinal lymphadenopathy or lymphadenitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Granuloma inguinale",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Femoral hernia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Appendicitis within the hernial sac (Amyand hernia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Benign or malignant tumor*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Male only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydrocele of the spermatic cord",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Retractile testis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ectopic or undescended testis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Traumatically dislocated testis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Female only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herniation of the ovary or fallopian tube",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Benign lesions of the inguinal canal can include, but are not limited to: lipomas, hematomas, mesothelial cyst , dermoid cysts. Soft tissue sarcomas comprise the most common malignant tumors of the groin.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24619=[""].join("\n");
var outline_f24_2_24619=null;
var title_f24_2_24620="Causes of lymphadenopathy";
var content_f24_2_24620=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F77382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F77382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of peripheral lymphadenopathy*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Cause",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\">",
"        Bacterial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Localized",
"       </td>",
"       <td class=\"sublist_other\">",
"        Streptococcal pharyngitis; skin infections; tularemia; plague; cat scratch disease; diphtheria; chancroid; rat bite fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Generalized",
"       </td>",
"       <td class=\"sublist_other\">",
"        Brucellosis; leptospirosis; lymphogranuloma venereum; typhoid fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Viral",
"       </td>",
"       <td>",
"        Human immunodeficiency virus; Epstein-Barr virus; herpes simplex virus; cytomegalovirus; mumps; measles; rubella; hepatitis B; dengue fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mycobacterial",
"       </td>",
"       <td>",
"        <em>",
"         Mycobacterium tuberculosis",
"        </em>",
"        ; atypical mycobacteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fungal",
"       </td>",
"       <td>",
"        Histoplasmosis; coccidioidomycosis; cryptococcosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Protozoal",
"       </td>",
"       <td>",
"        Toxoplasmosis; Leishmaniasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spirochetal",
"       </td>",
"       <td>",
"        Secondary syphilis; Lyme disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Cancer",
"       </td>",
"       <td>",
"        Squamous cell cancer head and neck; metastatic; lymphoma; leukemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"4\">",
"        Lymphoproliferative",
"       </td>",
"       <td>",
"        Angioimmunoblastic lymphadenopathy with dysproteinemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoimmune lymphoproliferative disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rosai-Dorfman disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemophagocytic lymphohistiocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Immunologic",
"       </td>",
"       <td>",
"        Serum sickness; drug reactions (phenytoin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Endocrine",
"       </td>",
"       <td>",
"        Hypothyroidism; Addison's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Miscellaneous",
"       </td>",
"       <td>",
"        Sarcoidosis; lipid storage diseases; amyloidosis; histiocytosis; chronic granulomatous diseases; Castleman's disease; Kikuchi's disease; Kawasaki disease; inflammatory pseudotumor; systemic lupus erythematosus; rheumatoid arthritis; Still's disease; dermatomyositis; Churg-Strauss syndrome",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Note: This is a partial list and is not meant to be all inclusive.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24620=[""].join("\n");
var outline_f24_2_24620=null;
var title_f24_2_24621="BP by doctor and nurse";
var content_f24_2_24621=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F73781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F73781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 472px\">",
"   <div class=\"ttl\">",
"    Effect of physician and nurse measurement of blood pressure during an office visit",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 452px; height: 224px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Increase in systolic pressure, determined by continuous intra-arterial monitoring, in 30 hypertensive patients as the blood pressure is taken with a sphygmomanometer by an unfamiliar doctor or nurse. A new doctor's visit raised the systolic pressure by a mean of 22 mmHg within the first few minutes, an effect that attenuated within 5 to 10 minutes and that was less pronounced with a nurse's visit. The alerting effect of the new physician's visit persisted for four daily visits in this study but typically diminished with increasing familiarity. A similar pattern was seen with the diastolic pressure, with the peak increase being 13 mmHg during a physician's visit.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Mancia G, Parati G, Pomidossi G, et al. Hypertension 1987; 9:209.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24621=[""].join("\n");
var outline_f24_2_24621=null;
var title_f24_2_24622="Contents: Pediatric otolaryngology";
var content_f24_2_24622=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric otolaryngology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric otolaryngology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Congenital anomalies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/36/44615\">",
"           Ankyloglossia (tongue-tie) in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/49/12055\">",
"           Congenital anomalies of the ear",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/59/1977\">",
"           Congenital anomalies of the jaw, mouth, oral cavity, and pharynx",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/42/37543\">",
"           Congenital anomalies of the larynx",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/47/35575\">",
"           Congenital anomalies of the nose",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Epistaxis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/16/27912\">",
"           Epidemiology and etiology of epistaxis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/42/18086\">",
"           Evaluation of epistaxis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/58/26536\">",
"           Management of epistaxis in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hearing loss",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/36/35397\">",
"           Ear barotrauma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/38/19050\">",
"           Etiology of hearing impairment in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/19/44344\">",
"           Evaluation of hearing impairment in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/13/27865\">",
"           Screening the newborn for hearing loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/14/29927\">",
"           Treatment of hearing impairment in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hoarseness",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/29/44505\">",
"           Etiology and management of hoarseness in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/0/4102\">",
"           Evaluation of the child with hoarseness",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/16/5385\">",
"           Acute mastoiditis in children: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/5/16471\">",
"           Acute mastoiditis in children: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/35/8760\">",
"           Acute otitis media in children: Diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/60/29642\">",
"           Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/0/21514\">",
"           Acute otitis media in children: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/28/41417\">",
"           Approach to diagnosis of acute infectious pharyngitis in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/26/31144\">",
"           Approach to the management of croup",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/32/43529\">",
"           Clinical features, evaluation, and diagnosis of croup",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/17/24857\">",
"           Diagnostic approach to and initial treatment of cervical lymphadenitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/45/4826\">",
"           Epiglottitis (supraglottitis): Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/27/8632\">",
"           Etiology and clinical manifestations of cervical lymphadenitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/62/32743\">",
"           External otitis: Pathogenesis, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/40/22153\">",
"           Otitis media with effusion (serous otitis media) in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/11/31928\">",
"           Pharmacologic and supportive interventions for croup",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/61/43992\">",
"           Retropharyngeal infections in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/26/8616\">",
"           Acquired torticollis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/33/12823\">",
"           Cerumen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/51/42808\">",
"           Cholesteatoma in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/22/35178\">",
"           Tonsillectomy and adenoidectomy in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Trauma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/29/6615\">",
"           Jaw fractures in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/50/33575\">",
"           Nasal trauma and fractures in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tympanostomy tubes",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/56/3978\">",
"           Overview of tympanostomy tube placement and medical care of children with tympanostomy tubes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/38/36457\">",
"           Prevention and management of tympanostomy tube otorrhea in children",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-E3682BDCA5-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f24_2_24622=[""].join("\n");
var outline_f24_2_24622=null;
var title_f24_2_24623="Vacuum constrictor device";
var content_f24_2_24623=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F54878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F54878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vacuum constrictor device",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 232px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A vacuum-constrictor device causes an erection by creating a partial vacuum around the penis, which draws blood into the corpora cavernosa. Pictured here are the necessary components: (a) a plastic cylinder, which covers the penis; (b) a pump, which draws air out of the cylinder; and (c) an elastic ring, which, when fitted over the base of the penis, traps the blood and sustains the erection after the cylinder is removed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_2_24623=[""].join("\n");
var outline_f24_2_24623=null;
